Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1050.Time spend outdoors in summer,50239,0.00403146841975354,0.0142003945226801,-0.0238013048446994,0.0318642416842065,0.776491082371549
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1060.Time spent outdoors in winter,48093,0.012947896852844,0.0157660316790858,-0.0179535252381642,0.0438493189438522,0.411512676030705
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X1070.Time spent watching television (TV),51440,0.0031543227033054,0.0144627413614347,-0.0251926503651065,0.0315012957717173,0.82735326195226
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X1080.Time spent using computer,48162,-0.0385847577008786,0.014124614571862,-0.0662690022617281,-0.0109005131400291,0.00630593385591276
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X1090.Time spent driving,43937,-0.0184590264404427,0.0164389509933696,-0.0506793703874471,0.0137613175065618,0.261505272605111
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1160.Sleep duration,52242,-0.0112486738896863,0.0126846007822731,-0.0361104914229415,0.0136131436435689,0.375197118125508
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,35635,-0.00579460441116952,0.0403847042793143,-0.0849486247986256,0.0733594159762865,0.885911545399669
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,35635,0.0372384045694699,0.0386290496128618,-0.0384745326717392,0.112951341810679,0.335082106533185
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,35635,0.000838822322692813,0.0422544929990177,-0.0819799839553819,0.0836576286007676,0.984162312832649
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,35635,0.0415694621184763,0.0426238752445952,-0.0419733333609303,0.125112257597883,0.329466750532605
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,35635,0.0315539542264669,0.0425735185255173,-0.051890142083547,0.114998050536481,0.458621100384102
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,35635,-0.122653291114387,0.106728034217783,-0.331840238181242,0.086533655952467,0.250510653102457
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,35635,-0.104324314843952,0.112267718588109,-0.324369043276646,0.115720413588741,0.352796498749365
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,35635,-0.0783596746783803,0.0731611662031081,-0.221755560436472,0.0650362110797115,0.284184574598727
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,35635,-0.0443408545046739,0.0527609898293188,-0.147752394570139,0.0590706855607909,0.400709834489094
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,35635,0.00534423276519566,0.0346414444904937,-0.062552998436172,0.0732414639665633,0.877399473518397
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,35635,-0.00927130578916099,0.0519316069320992,-0.111057255376075,0.0925146437977534,0.858313043091125
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,35635,-0.00839515586345099,0.0278840719823699,-0.063047936948896,0.046257625221994,0.763368146662198
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,35635,-0.01162133681453,0.0365634511722427,-0.0832857011121256,0.0600430274830656,0.750616413729767
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,35635,0.0530554136104884,0.0519779673392608,-0.0488214023744628,0.15493222959544,0.307421232800358
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,35635,-0.10494725391587,0.0488946256235806,-0.200780720138088,-0.00911378769365218,0.0318785988191393
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,35635,0.0411999800505849,0.0761872493473145,-0.108127028670151,0.190526988771321,0.588683002321203
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,35635,-0.0496604204143549,0.0723461408548802,-0.19145885648992,0.0921380156612103,0.49246793035229
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,35635,0.0527206407717917,0.0380319754169915,-0.0218220310455118,0.127263312589095,0.165728074498194
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,35635,-0.0160793605523337,0.0359095753094286,-0.0864621281588139,0.0543034070541464,0.654331642377777
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,35635,0.0892973697212275,0.0457233762144631,-0.000320447659120288,0.178915187101575,0.0508638354356693
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120040.Fatigue severity over the past week,35640,-0.0311037684664526,0.0246474598018983,-0.0794127896781732,0.017205252745268,0.207013815651322
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120041.Waking unrefreshed severity over the past week,35637,-0.0421363095461324,0.0246130464180579,-0.090377880525526,0.00610526143326111,0.0869539854129663
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120042.Cognitive symptoms severity over the past week,35640,0.0196117165279953,0.0261783459903308,-0.0316978416130531,0.0709212746690437,0.453789343917671
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120098.Mobility problems today,35643,-0.00819813260483076,0.026929253854463,-0.0609794701595783,0.0445832049499168,0.760808449337034
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120099.Self-care problems today,35643,-0.0138015162822184,0.0414524980076771,-0.0950484123772655,0.0674453798128287,0.73918454610333
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120100.Problems doing usual activities,35643,-0.00565163064368725,0.0263133671041987,-0.0572258301679167,0.0459225688805422,0.829944288175654
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120101.Pain or discomfort today,35643,-0.00530231483878258,0.0245591001975721,-0.053438151226024,0.0428335215484588,0.829072366252999
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120102.Anxiety or depression today,35643,-0.000883294760884376,0.0310997205283979,-0.0618387469965443,0.0600721574747756,0.977342395530327
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120103.Scale to indicate how health is today,35622,0.0218668582274638,0.0121976144637585,-0.00204046612150287,0.0457741825764304,0.0730653546561829
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,35620,-0.00987393551678817,0.0317994815059403,-0.0722009192684312,0.0524530482348549,0.756186134253352
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",35611,-0.0377446977175486,0.0331888542768066,-0.10279485210009,0.0273054566649923,0.255467790112715
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",35625,-0.0227777224944677,0.0249474501733409,-0.0716747248342158,0.0261192798452804,0.361262011279684
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,35624,-0.0470188621175595,0.0254598696626073,-0.0969202066562698,0.00288248242115086,0.0648244862327649
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,35636,-0.0247995402673854,0.0367991333127263,-0.096925841560329,0.0473267610255581,0.50038863769048
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120109.Feeling bad about self over the last two weeks,35616,-0.0519330453334827,0.0357717054611663,-0.122045588037369,0.0181794973704033,0.146608550372668
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120110.Trouble concentrating over the last two weeks,35629,-0.00874193174461755,0.0354226272009584,-0.078170281058496,0.0606864175692609,0.805079027249273
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,35627,-0.0223771962210301,0.0490977456501012,-0.118608777695228,0.0738543852531683,0.648571988021452
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,35605,-0.151464199329377,0.0735661403162926,-0.29565383434931,-0.00727456430944312,0.0395456073092304
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",33472,0.028091722421373,0.0352427466326829,-0.0409840609786854,0.0971675058214314,0.425441676976688
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,50429,0.0261136268357663,0.0317469735099189,-0.0361104412436747,0.0883376949152073,0.410770423250882
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,48632,0.0595221915063335,0.0194890181458522,0.0213237159404631,0.0977206670722039,0.00226012017699408
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1289.Cooked vegetable intake,51794,-0.00136355882028816,0.0134041826016339,-0.0276357567194905,0.0249086390789142,0.918974774085429
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50979,-0.0291416881279495,0.0139551527351149,-0.0564937874887746,-0.00178958876712431,0.0367879035658728
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1309.Fresh fruit intake,51706,-0.01986955354608,0.0137757196248387,-0.0468699640107638,0.00713085691860383,0.14921461967029
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1319.Dried fruit intake,50502,-0.0111881762059408,0.0138143937646315,-0.0382643879846186,0.015888035572737,0.418010911483593
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X134.Number of self-reported cancers,52452,0.0068170150346929,0.0213001021010799,-0.0349311850834237,0.0485652151528095,0.748936244271665
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X135.Number of self-reported non-cancer illnesses,52453,0.0231660272679692,0.0137639675145973,-0.00381134906064159,0.0501434035965799,0.0923706528690714
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X136.Number of operations, self-reported",52453,-0.0163625720336491,0.0133464910216592,-0.0425216944361011,0.00979655036880287,0.220217459112474
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X137.Number of treatments or medications taken,52453,0.0247224741741935,0.013211774938615,-0.00117260470549184,0.0506175530538789,0.0613236076047308
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1438.Bread intake,51830,-0.00183128259110209,0.00685313319178739,-0.0152634236470054,0.0116008584648012,0.789303522474133
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1458.Cereal intake,51471,-0.0113183964036146,0.0131407031244285,-0.0370741745274944,0.0144373817202652,0.389069167405483
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1488.Tea intake,51746,0.00904117830713993,0.00664139554416424,-0.00397595695942198,0.0220583135737019,0.173420777217782
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1498.Coffee intake,50740,0.0249965938337167,0.0132560323644899,-0.000985229600683556,0.0509784172681169,0.059351950731902
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1528.Water intake,50564,-0.00738451366105827,0.0133081669654557,-0.0334685209133515,0.018699493591235,0.578978542505444
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1568.Average weekly red wine intake,45070,-0.0261708549821095,0.0152704079409198,-0.0561008545463123,0.00375914458209326,0.0865798135306241
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,45067,0.00689634461933234,0.0155831731452323,-0.023646674745323,0.0374393639839876,0.658096761029542
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1588.Average weekly beer plus cider intake,45115,0.0158784667478112,0.0175725203107066,-0.0185636730611738,0.0503206065567961,0.366223103329571
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1598.Average weekly spirits intake,45052,-0.030112217545975,0.0164190889042123,-0.062293631798231,0.00206919670628104,0.0666762629783744
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1608.Average weekly fortified wine intake,45101,0.0308663623528801,0.0247587322600631,-0.0176607528768436,0.0793934775826038,0.21253104999306
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1737.Childhood sunburn occasions,46094,-0.0362286238151849,0.0160248854455044,-0.0676373992883735,-0.00481984834199636,0.0237859987844126
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X1807.Father's age at death,50310,-0.00121235603535024,0.00641761009157209,-0.0137908718148315,0.0113661597441311,0.850164522490658
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X1845.Mother's age,32624,0.0247991490655129,0.030086776037763,-0.0341709319685025,0.0837692300995283,0.409852494294968
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X1873.Number of full brothers,52028,0.00947051219403137,0.0127128470669414,-0.0154466680571738,0.0343876924452365,0.456305963654592
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X1883.Number of full sisters,52036,0.0358065314662022,0.0127459291437426,0.0108245103444668,0.0607885525879376,0.00496988887794366
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X20015.Sitting height,52282,-0.0253235147958039,0.00856489582231816,-0.0421107106075475,-0.00853631898406034,0.0031130192822583
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20016.Fluid intelligence score,36789,-0.0067296072843871,0.021612418817352,-0.049089948166397,0.0356307335976228,0.755522696589128
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20018.Prospective memory result,37152,0.023583542370857,0.026474233531459,-0.0283059553508026,0.0754730400925165,0.373057427304701
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),36662,-0.0166492141182644,0.0111241844031623,-0.0384526155484626,0.00515418731193376,0.134521848975051
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),36647,0.00887046317763778,0.0112076367713548,-0.0130965048942176,0.0308374312494931,0.428697310035152
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20023.Mean time to correctly identify matches,52143,-0.00600718250381193,0.00699233226267488,-0.0197121537386547,0.00769778873103084,0.390288809381423
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#1.Illnesses of father_Heart disease,48995,-0.00141788941797488,0.0145881265504429,-0.0300106174568429,0.0271748386208932,0.922572715193289
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48540,-0.0560382116723772,0.031005501699672,-0.116808995003734,0.00473257165897989,0.0707211501802153
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48505,0.0239492676156073,0.0414633659477455,-0.0573189296419739,0.105217464873188,0.563540494187833
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#12.Illnesses of father_Severe depression,48513,0.0357015094728403,0.0395501259882738,-0.0418167374641764,0.113219756409857,0.366701615958798
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48536,0.00804510819716523,0.0274213140932337,-0.0457006674255728,0.0617908838199033,0.769228083882384
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#2.Illnesses of father_Stroke,48715,-0.0191440996833977,0.0182849955290211,-0.0549826909202791,0.0166944915534837,0.295119872204526
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48657,0.000696451955866735,0.0223451089771022,-0.0430999616392536,0.0444928655509871,0.975135893697701
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48557,-0.0137582616695663,0.0289954186990339,-0.0705892823196727,0.0430727589805402,0.635150334978982
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48712,0.0133347789019289,0.0197877553712593,-0.0254492216257393,0.0521187794295971,0.500388959499433
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48701,-0.0219496986211176,0.0183503055324506,-0.0579162974647208,0.0140169002224856,0.231652978592835
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48577,-0.027047979869199,0.0261937315199747,-0.0783876936483495,0.0242917339099514,0.301798065406791
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,50122,-0.0133269665725923,0.0158537381734587,-0.0444002933925714,0.0177463602473868,0.400570553909379
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49962,0.0420933356535842,0.0206425517675433,0.00163393418919928,0.0825527371179691,0.0414473240564049
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49868,0.0139555546018743,0.045956566853509,-0.0761193164310034,0.104030425634752,0.761383632647699
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49894,0.006677906157394,0.0287705035476246,-0.0497122807959503,0.0630680931107383,0.81645528889636
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#2.Illnesses of mother_Stroke,50050,-0.00582574714520476,0.0174031825809788,-0.0399359850039232,0.0282844907135136,0.737815669584391
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49914,-0.0295952603891102,0.0333290574971608,-0.0949202130835454,0.0357296923053249,0.374566273074628
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49899,0.00571906037816513,0.0281206546662882,-0.0493974227677598,0.0608355435240901,0.838843319183686
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49902,0.0205425895581719,0.0247998929336381,-0.0280652005917588,0.0691503797081026,0.407491032375125
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49953,0.0525768902283088,0.0276940453387898,-0.00170343863571912,0.106857219092337,0.0576453133741633
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,50098,-0.00359724940747121,0.0154472855941874,-0.0338739291720785,0.0266794303571361,0.815862623173019
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49964,0.00496165224338333,0.0236257327405116,-0.0413447839280193,0.051268088414786,0.833661528042825
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46274,-0.0171350827564051,0.0198944959119129,-0.0561282947437543,0.0218581292309442,0.389086215606121
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46100,0.012051958987528,0.0689529218502491,-0.12309576783896,0.147199685814016,0.861250411310178
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46091,0.107642913543747,0.0736121573495901,-0.0366369148614492,0.251922741948944,0.143678152998825
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46123,-0.0359194163409429,0.0304287666435369,-0.0955597989622752,0.0237209662803895,0.237840761368564
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46116,0.00375728946685575,0.0413597893920422,-0.077307897741547,0.0848224766752585,0.927617608261457
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46151,0.0083177561057294,0.0331546120115778,-0.0566652834369632,0.073300795648422,0.801911628723162
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46115,0.0819984102751854,0.0369858341645588,0.00950617531265013,0.154490645237721,0.0266348244864343
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46108,-0.0366158071406785,0.0374221942266251,-0.109963307824864,0.0367316935435066,0.327864994926644
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46128,-0.00576689500521965,0.0305459007804973,-0.0656368605349943,0.054103070524555,0.850256223637203
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46144,-0.0176355390760352,0.0360006224344369,-0.0881967590475315,0.0529256808954612,0.624233920247085
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46323,-0.0372156581834428,0.0167567333940715,-0.0700588556358229,-0.00437246073106274,0.026368219961292
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46210,0.00915893570593904,0.0230191622669836,-0.0359586223373488,0.0542764937492268,0.690721347410824
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20127.Neuroticism score,47461,-0.000699543285108654,0.0133359566792685,-0.0268380183764748,0.0254389318062575,0.958166385449883
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,36789,0.0206085942318607,0.0218816652540426,-0.0222794696660628,0.0634966581297841,0.346314702482751
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X20161.Pack years of smoking,37059,0.0209728746659322,0.011412673036273,-0.00139596448516292,0.0433417138170274,0.0661468309942195
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,37059,0.0201030193462635,0.0117916896737323,-0.00300869241425182,0.0432147311067787,0.0882625680211631
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20191.Fluid intelligence score,34367,-0.032574253366407,0.0253942858412624,-0.0823470536152812,0.0171985468824673,0.199640963243548
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,34368,-0.0025770595552161,0.0258858311612368,-0.0533132886312402,0.048159169520808,0.920701620820808
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20240.Maximum digits remembered correctly,33723,-0.0345181226347147,0.0278470753637951,-0.0890983903477531,0.0200621450783238,0.215202497264314
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X20255.Spirometry QC measure,46364,0.0286758863322538,0.0168180262218333,-0.00428744506253952,0.0616392177270471,0.0881997413251625
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X20261.avMSE,34370,-0.0267683779870421,0.0124909690592584,-0.0512506773431886,-0.00228607863089561,0.0321580992517264
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X20262.Myopia diagnosis,34370,0.0338066658656868,0.0344002288531515,-0.0336177826864902,0.101231114417864,0.325778713501411
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X20280.Glucose-lactate,42643,0.0826683066014159,0.00848075014077009,0.0660460363255065,0.0992905768773253,2.236536574482e-22
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X20281.Spectrometer-corrected alanine,42670,0.0880183626190801,0.00868453935409273,0.0709966654850584,0.105040059753102,4.70917198153613e-24
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,36473,0.0161949747226042,0.0542482413773769,-0.0901315783770544,0.122521527822263,0.76530372652707
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,36473,-0.0403716335530976,0.101635324466477,-0.239576869507392,0.158833602401197,0.691216519013864
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),36474,0.15386841886389,0.170492835770416,-0.180297539246126,0.488034376973906,0.366825432371241
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),36474,-0.0401909259009169,0.0496709554605809,-0.137545998603655,0.0571641468018216,0.418459108809529
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),36474,0.0532563449683085,0.104228679934774,-0.151031867703849,0.257544557640466,0.609396853611615
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,36477,0.0669026979389868,0.131064748239719,-0.189984208610862,0.323789604488836,0.609747979818836
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,36477,0.0919488300483289,0.0807440573249245,-0.0663095223085231,0.250207182405181,0.25483696708689
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,36477,-0.156593278498303,0.0970393956765614,-0.346790494024364,0.0336039370277572,0.106634034893032
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,36477,0.136008714317584,0.151092474154179,-0.160132535024607,0.432149963659775,0.368060249366431
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,36477,0.260803781453296,0.175805389708642,-0.0837747823756412,0.605382345282234,0.137990195429411
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,36477,-0.280761073817603,0.106682108296095,-0.489858006077949,-0.0716641415572563,0.00851244185525234
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,36477,0.360310272813347,0.181672051347141,0.0042330521729515,0.716387493453744,0.0473713687478027
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,36477,-0.0458749713387766,0.125670373521083,-0.2921889034401,0.200438960762547,0.715090613960143
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),36476,0.064203938496799,0.172982442394509,-0.274841648596438,0.403249525590036,0.710530129264852
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),36476,-0.033133111723475,0.0674069844162363,-0.165250801179298,0.0989845777323482,0.623060614562745
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),36476,0.180041755976926,0.124640114163937,-0.0642528677843903,0.424336379738242,0.148643408932006
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,36478,-0.120108721301816,0.218912912777977,-0.549178030346652,0.308960587743019,0.583255734944158
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20600.Liking for adding salt to foods,36293,0.0119602424236792,0.0218208585958365,-0.0308086404241603,0.0547291252715187,0.583633265021715
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20601.Liking for aniseed,36293,-0.0112922784276043,0.0215843294612191,-0.0535975641715938,0.0310130073163852,0.600872151481742
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20602.Liking for apple juice,36293,0.018827940914785,0.0216920964986485,-0.023688568222566,0.061344450052136,0.385443869957929
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20603.Liking for apples,36293,-0.0241796250461186,0.0223185251191636,-0.0679239342796793,0.0195646841874421,0.278673026352345
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20604.Liking for asparagus,36293,0.006866985539381,0.0220619853511848,-0.0363745057489412,0.0501084768277032,0.755613089795652
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20605.Liking for aubergine,36293,-0.00840677131303312,0.0216600570267852,-0.0508604830855321,0.0340469404594659,0.697936493777342
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20606.Liking for avocados,36293,0.0453705149528062,0.0218998052132667,0.00244689673480356,0.0882941331708089,0.0383265700411172
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20607.Liking for bacon,36293,-0.00259575209373261,0.0221162947645913,-0.0459436898323316,0.0407521856448664,0.906571521597116
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20608.Liking for baked or steamed fish,36293,0.0185166910201705,0.0222134281507829,-0.0250216281553639,0.0620550101957049,0.404545233169613
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20609.Liking for bananas,36293,0.0230983377997171,0.0225873284466333,-0.0211728259556842,0.0673695015551184,0.30652068122087
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,36293,-0.0275686417072148,0.0219414104039149,-0.070573806098888,0.0154365226844583,0.208988370029542
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20611.Liking for beef steak,36293,-0.0197563768851363,0.0219639988766873,-0.0628058146834433,0.0232930609131707,0.368422764075211
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20612.Liking for beetroot,36293,0.0151233655329303,0.022112919431723,-0.0282179565532468,0.0584646876191073,0.494050957655429
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20613.Liking for bell pepper,36293,0.00378348132883271,0.0218241876561664,-0.0389919264772534,0.0465588891349189,0.862371967110114
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20614.Liking for bicycling,36293,-0.0152494945785255,0.0218848170597117,-0.0581437360155604,0.0276447468585095,0.485946404960124
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20615.Liking for biscuits,36293,0.0246354967691859,0.0218038794129904,-0.0181001068802753,0.0673711004186471,0.258570243497488
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20616.Liking for bitter foods,36293,-0.0166025764428561,0.0218123185778361,-0.0593547208554149,0.0261495679697027,0.446589229618717
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20617.Liking for bitter or ale,36293,-0.0254600883778148,0.0223806727337956,-0.0693262069360543,0.0184060301804247,0.255329067102361
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20618.Liking for black olives,36293,-0.00912986606618236,0.0218408535063286,-0.0519379389385865,0.0336782068062218,0.675946744682471
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20619.Liking for black pepper,36293,-0.000871434181082016,0.0220026701458669,-0.0439966676669812,0.0422537993048172,0.96840848847174
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20620.Liking for blue cheese,36293,0.0172186021354752,0.0218259252446203,-0.0255602113439806,0.0599974156149309,0.430193360515616
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20621.Liking for bolognese sauce,36293,-0.0187687623400323,0.0218982216939376,-0.0616892768601499,0.0241517521800854,0.391423724728322
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20622.Liking for broad beans,36293,0.00944844583409792,0.0219428878322079,-0.0335596143170295,0.0524565059852254,0.666777687982677
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20623.Liking for broccoli,36293,0.013948414154523,0.0223941327371052,-0.0299440860102031,0.0578409143192491,0.533396422547658
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20624.Liking for brown rice,36293,0.0100436139101631,0.0218142511577758,-0.0327123183590774,0.0527995461794036,0.645232310414221
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20625.Liking for brussel sprouts,36293,0.0134229037241972,0.0220525925011461,-0.0298001775780492,0.0566459850264436,0.542758118880558
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20626.Liking for burgers (meat),36293,-0.0450997822297296,0.0218112161423599,-0.0878497658687551,-0.0023497985907041,0.0387012824926825
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20627.Liking for burn of spicy foods,36293,-0.0145921498262639,0.0218840043922299,-0.0574847984350346,0.0283004987825067,0.504924635588499
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20628.Liking for butter on bread,36293,0.0127769483566,0.0220360052588369,-0.0304136219507202,0.0559675186639202,0.5620534600219
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20629.Liking for butternut squash,36293,-0.0263494822049796,0.0216718391028394,-0.0688262868465449,0.0161273224365857,0.224086474859048
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20630.Liking for cabbage,36293,0.0213195028039281,0.0221302756115826,-0.0220558373947738,0.06469484300263,0.335397923111823
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20631.Liking for cake,36293,0.0224225631554156,0.0218354356110717,-0.0203748906422849,0.0652200169531162,0.304507884899198
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20632.Liking for cake icing,36293,0.025031453941182,0.0216622573347833,-0.0174265704349934,0.0674894783173573,0.247911152274039
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20633.Liking for capers,36293,-0.0255637168889313,0.0216682293335975,-0.0680334463827824,0.0169060126049197,0.238127800044202
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20634.Liking for cauliflower,36293,0.0124738312823706,0.0222049991585167,-0.0310479670683222,0.0559956296330633,0.57429881030231
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20635.Liking for cereal or granola bar,36293,0.01726985731923,0.0217327423297996,-0.0253263176471773,0.0598660322856373,0.426845500004332
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20636.Liking for cheesecake,36293,0.0267709629060052,0.0217359340553154,-0.015831467842413,0.0693733936544235,0.218122427346486
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20637.Liking for cherries,36293,0.0291705232668211,0.0232003823790361,-0.0163022261960897,0.074643272729732,0.2086757902067
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20638.Liking for chicken,36293,-0.0297829544731362,0.0229251454968897,-0.0747162396470399,0.0151503307007676,0.193938417640914
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20639.Liking for chilli pepper,36293,-0.0298686464323838,0.021807809487733,-0.0726119530283405,0.0128746601635729,0.170845572176384
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20640.Liking for chips or french fries,36293,-0.0345167001881053,0.0218206346063463,-0.0772851440165442,0.00825174364033353,0.113731254647273
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20641.Liking for cigarette smoking,36293,-0.0212347943222976,0.0370289805570432,-0.0938115962141023,0.051342007569507,0.566348627791328
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20642.Liking for cod,36293,0.00904508691526966,0.0227425766413755,-0.0355303633018263,0.0536205371323657,0.690851505782819
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20643.Liking for coffee with sugar,36293,-0.0175368843111858,0.0239313476985635,-0.0644423258003703,0.0293685571779987,0.463704832430044
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20644.Liking for coffee without sugar,36293,0.028391697593493,0.0221974991779787,-0.0151154007953453,0.0718987959823313,0.200921526991541
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20645.Liking for coriander,36293,-0.0537293103533736,0.0218815391449511,-0.0966171270774778,-0.0108414936292695,0.0140941549697969
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20646.Liking for corn flakes,36293,0.0229721510362593,0.0217005395633668,-0.0195609065079396,0.0655052085804582,0.289818893660308
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20647.Liking for cream,36293,0.0247785868310721,0.021732553424679,-0.0178172178812987,0.0673743915434429,0.254258187458218
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20648.Liking for croissant,36293,0.00178229801402286,0.0217560979930217,-0.0408596540522997,0.0444242500803454,0.934711236650811
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20649.Liking for cucumber,36293,-0.0207323304734672,0.021910597740459,-0.063677102044767,0.0222124410978325,0.344066662686206
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20650.Liking for curry,36293,-0.0270296987688022,0.021943939468953,-0.0700398201279501,0.0159804225903456,0.218079057536397
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20651.Liking for dairy products,36293,0.0507106182221336,0.0220653464331161,0.0074625392132261,0.093958697231041,0.0215792732103396
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20652.Liking for dark chocolate,36293,-0.00220178657462497,0.0221246204644058,-0.0455660426848603,0.0411624695356104,0.920730219721233
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20653.Liking for diet fizzy drinks,36293,-0.0254391485868949,0.022754689980981,-0.0700383409496176,0.0191600437758278,0.263616037034166
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20654.Liking for dried fruit,36293,0.0119710236526962,0.0219447266866664,-0.03104064065317,0.0549826879585623,0.585421350605321
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20655.Liking for eggs,36293,0.0259674785493267,0.0226312042936841,-0.0183896818662941,0.0703246389649476,0.251247122048026
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20656.Liking for exercising alone,36293,0.000930825033949721,0.0218415930024865,-0.0418786972509239,0.0437403473188233,0.966007975756728
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20657.Liking for exercising with others,36293,0.0157474275506649,0.0218816120731728,-0.0271405321127539,0.0586353872140836,0.47175508080639
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20658.Liking for extra virgin olive oil,36293,-0.00641914446181361,0.0219721566344423,-0.0494845714653204,0.0366462825416932,0.770181221085911
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20659.Liking for fatty foods,36293,-0.0010116110412723,0.0218518787906427,-0.0438412934709321,0.0418180713883875,0.963077219302028
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20660.Liking for fresh tomatoes,36293,-0.00406907237259817,0.0234655575841687,-0.0500615652375689,0.0419234204923726,0.862337129053855
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20661.Liking for fried chicken,36293,-0.0298915501747691,0.0217898957093137,-0.072599745765024,0.0128166454154858,0.170166665615966
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20662.Liking for fried or battered fish,36293,0.0171566605035188,0.0219361334029626,-0.0258381609662879,0.0601514819733256,0.434170926711331
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20663.Liking for fruit,36293,0.00778182259761998,0.0248213126561363,-0.0408679502084071,0.0564315954036471,0.753899605067237
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20664.Liking for garlic,36293,-0.0268858922138821,0.0218151845797548,-0.0696436539902016,0.0158718695624374,0.217825870633392
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20665.Liking for gherkins,36293,-0.0139063828086026,0.0217563412545908,-0.0565488116676005,0.0287360460503954,0.522721569502853
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20666.Liking for globe artichoke,36293,0.0197649544402177,0.0218430682665089,-0.0230474593621398,0.0625773682425751,0.365569440446323
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20667.Liking for goat's cheese,36293,0.00511294012526324,0.021857354804391,-0.0377274752913432,0.0479533555418696,0.815051435785886
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20668.Liking for going to a cafe,36293,-0.02181209341216,0.0219623628190901,-0.0648583245375767,0.0212341377132566,0.320666920289006
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20669.Liking for going to the gym,36293,0.0148567977760206,0.0217025862011253,-0.027680271178185,0.0573938667302262,0.493641799654319
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20670.Liking for going to the pub,36293,-0.00799684526942096,0.0218479009360436,-0.0508187311040665,0.0348250405652246,0.714358457194212
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20671.Liking for grapefruit,36293,0.0257232976714115,0.0216969573133085,-0.0168027386626731,0.0682493340054962,0.235831232716995
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20672.Liking for green olives,36293,0.0138995989800186,0.0217896701975923,-0.0288081546072622,0.0566073525672995,0.523560323716355
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20673.Liking for haddock,36293,-0.0296005202888051,0.0225480986249383,-0.0737947935936841,0.0145937530160739,0.18930216191112
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20674.Liking for ham,36293,-0.00916579831869652,0.0220050386189024,-0.0522956740117453,0.0339640773743522,0.677033512678132
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20675.Liking for hard cheese,36293,0.0107853171146783,0.0222258179240504,-0.0327772860164605,0.054347920245817,0.627506385939586
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20676.Liking for herring,36293,-0.00495263236357454,0.0217376243784045,-0.0475583761452473,0.0376531114180982,0.81977962986111
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20677.Liking for honey,36293,0.0470889015766748,0.0217382803040608,0.00448187218071562,0.0896959309726339,0.0303310954827806
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20678.Liking for horseradish or wasabi,36293,0.00949246287609848,0.0217679424408115,-0.033172704307892,0.0521576300600889,0.662795346108422
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20679.Liking for ice cream,36293,0.00520528188265146,0.0220793818191446,-0.0380703064828719,0.0484808702481748,0.813631101563123
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20680.Liking for jam,36293,0.0248147313251167,0.0217594817977715,-0.0178338529985154,0.0674633156487489,0.254154036682409
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20681.Liking for kiwi fruit,36293,0.0034451640789366,0.0218300940584705,-0.0393418202756656,0.0462321484335388,0.874605347808988
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20682.Liking for lager,36293,-0.0331587291909363,0.0219944821679618,-0.0762679142401413,0.00995045585826881,0.131703258384878
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20683.Liking for lamb,36293,0.006400556211756,0.0221395215881739,-0.0369929061010648,0.0497940185245768,0.772512596856791
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20684.Liking for lemons,36293,-0.0119583130115227,0.0218710729769834,-0.0548256160464101,0.0309089900233647,0.584558158776856
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20685.Liking for lentils or beans,36293,-0.0261731629278495,0.0219141644737985,-0.0691249252964947,0.0167785994407956,0.232381387863054
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20686.Liking for liver,36293,0.0473716942739852,0.0218227038699801,0.00459919468882423,0.0901441938591461,0.0299829406706884
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20687.Liking for mackerel,36293,0.0139252125994027,0.021917070109875,-0.0290322448159524,0.0568826700147578,0.525214662175599
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20688.Liking for marzipan,36293,0.00737148571491759,0.0217093751660543,-0.0351788896105489,0.0499218610403841,0.734203157120938
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20689.Liking for mayonnaise,36293,-0.0266702504077594,0.0217980172388549,-0.069394364195915,0.0160538633803961,0.221175048603552
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20690.Liking for melon,36293,0.0391025062541447,0.0225406704654796,-0.00507720785819527,0.0832822203664846,0.0828279395833421
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20691.Liking for milk chocolate,36293,-0.0140995117244035,0.0218331502437974,-0.0568924862022464,0.0286934627534394,0.518439776114334
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20692.Liking for mushrooms,36293,0.0513240045784469,0.0224756975346749,0.00727163741048419,0.0953763717464096,0.022428416675589
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20694.Liking for orange juice,36293,0.00593203912751985,0.0217631567415302,-0.0367237480858793,0.048587826340919,0.78518975293479
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20695.Liking for oranges,36293,-0.00877735592077239,0.0223147854780568,-0.0525143354577636,0.0349596236162188,0.694078279376218
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20696.Liking for pasta,36293,0.0185383147927889,0.0220460373394978,-0.0246719183926268,0.0617485479782046,0.400437348350323
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20697.Liking for pears,36293,0.0190629176361936,0.0225139614186658,-0.0250644467443914,0.0631902820167786,0.397182356038495
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20698.Liking for pizza,36293,-0.0611739514733287,0.0217665955326587,-0.10383647871734,-0.0185114242293176,0.00496077726465271
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20699.Liking for plain yogurt,36293,0.0269229052503058,0.0218562365180578,-0.0159153183250875,0.0697611288256992,0.218057935501185
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20700.Liking for plums,36293,0.0146672986937533,0.0224339327713923,-0.0293032095381756,0.0586378069256821,0.513262058269514
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20701.Liking for pollock,36293,0.0124684710682801,0.021805234394419,-0.030269788344781,0.0552067304813413,0.567468208119298
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20702.Liking for pork chop,36293,-0.0202528328600541,0.0218388944266748,-0.0630570659363367,0.0225514002162285,0.353763715537096
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20703.Liking for porridge,36293,0.0313028373464478,0.022300394532292,-0.0124059359368445,0.0750116106297401,0.160455024479582
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20704.Liking for potato crisps,36293,-0.00993809549507108,0.0218145473202174,-0.0526946082426972,0.032818417252555,0.648711781067579
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20705.Liking for potatoes,36293,0.00129080519977238,0.0221025043548102,-0.0420301033356557,0.0446117137352005,0.953430977614258
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20706.Liking for prawns,36293,0.0099240520836784,0.0222882115184167,-0.0337608424924184,0.0536089466597752,0.656145366724155
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20707.Liking for raw carrots,36293,0.00467682925398977,0.0219258631258594,-0.0382978624726946,0.0476515209806742,0.831097589325511
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20708.Liking for red meat,36293,-0.0219507240140566,0.0220128968090335,-0.0650960017597623,0.0211945537316491,0.318713303576307
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20709.Liking for red wine,36293,-0.0126083561051988,0.0218729480289152,-0.0554793342418725,0.030262622031475,0.564338771331079
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,36293,0.0113017672493115,0.0226356523838745,-0.0330641114230825,0.0556676459217054,0.61759020600808
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20711.Liking for roast chicken,36293,0.000569503655866891,0.0229651004763415,-0.0444420932777625,0.0455811005894963,0.980216259965503
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20712.Liking for salad dressing,36293,-0.0203718206645138,0.0218229995061312,-0.063144899696531,0.0224012583675034,0.350592462448548
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20713.Liking for salad leaves,36293,-0.00234741105370935,0.0221864725489479,-0.0458328972496473,0.0411380751422286,0.91574108825041
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20714.Liking for salami,36293,-0.0195982516210946,0.0218465727201503,-0.0624175341525891,0.0232210309104,0.369703559208437
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20715.Liking for salmon,36293,-0.0106994863478704,0.0230775473917587,-0.0559314792357175,0.0345325065399766,0.642925752600469
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20716.Liking for salty foods,36293,0.00457661131863711,0.0216605039071869,-0.0378779763394491,0.0470311989767234,0.832668374940696
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20717.Liking for salty pretzels,36293,0.0137641700349871,0.0216975917993312,-0.028763109891702,0.0562914499616762,0.525863797800147
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20718.Liking for sardines,36293,0.00973583049788726,0.0218631334593489,-0.0331159110824366,0.0525875720782111,0.656110707853345
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20719.Liking for sausages (meat),36293,-0.0410350344131785,0.0217922402354628,-0.0837478252746856,0.00167775644832851,0.0597397411983068
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20720.Liking for savoury biscuits,36293,0.0511433918884549,0.0219672715959946,0.00808753956030555,0.0941992442166043,0.019931425591257
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),36293,-0.000732240604348362,0.0217183739740808,-0.0433002535935467,0.04183577238485,0.973105160012429
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20722.Liking for skimmed milk,36293,0.014782481402926,0.0218629365435102,-0.0280688742223539,0.0576338370282059,0.498971625081275
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20723.Liking for smoked fish,36293,0.00402295534150686,0.0219879168647141,-0.0390733617133327,0.0471192723963465,0.854832991476976
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20724.Liking for soft cheese,36293,0.0121671700467994,0.0218390266072729,-0.0306373221034555,0.0549716621970542,0.577456412552078
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20725.Liking for soy sauce,36293,-0.0433043869867056,0.0218453843848036,-0.0861213403809208,-0.000487433592490497,0.0474827757171649
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20726.Liking for soya milk,36293,-0.016294762067441,0.0219680069493633,-0.0593520556881931,0.0267625315533111,0.458263584391636
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20727.Liking for spicy foods,36293,-0.0323519481603459,0.0218371165845425,-0.0751526966660493,0.0104488003453574,0.138514654736169
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20728.Liking for spinach,36293,0.0377952674165376,0.021941752546538,-0.00521056757467698,0.0808011024077521,0.0850176535809227
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20729.Liking for spirits,36293,-0.00377020235072567,0.0217112538025322,-0.0463242598036888,0.0387838551022375,0.862143930848459
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20730.Liking for strawberries,36293,-0.0059708212056299,0.0239453747285072,-0.0529037556735041,0.0409621132622443,0.803095924060642
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,36293,0.00309542572951249,0.0222393790174689,-0.0404937571447265,0.0466846086037515,0.889306572909571
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20732.Liking for sweet foods,36293,0.00324891827165307,0.0217134601186833,-0.0393094635609662,0.0458073001042724,0.881063220020142
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20733.Liking for taking the stairs,36293,0.0109771628276168,0.0221695999300839,-0.0324752530353475,0.0544295786905812,0.620513233999001
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20734.Liking for tea with sugar,36293,-0.0137674155733369,0.0267188609984112,-0.0661363831302228,0.0386015519835491,0.606380736210553
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20735.Liking for tea without sugar,36293,-0.019472153563782,0.0228074532899015,-0.064174762011989,0.025230454884425,0.393265312942929
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20736.Liking for tomato ketchup,36293,0.0138041682063359,0.0216088235530626,-0.0285491259576668,0.0561574623703386,0.52296008304598
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20737.Liking for tinned tuna,36293,0.00886418571915377,0.0218474319676426,-0.0339567809374257,0.0516851523757332,0.684952327153722
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20738.Liking for turnip (white),36293,0.0098016460199264,0.0217680013037319,-0.0328636365353882,0.0524669285752409,0.652523968667659
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20739.Liking for vegetables,36293,0.0261020334006493,0.0240283394549199,-0.0209935119309938,0.0731975787322924,0.277382329829227
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20740.Liking for vinegar,36293,-0.00539309705323571,0.0218569274968297,-0.048232674947022,0.0374464808405505,0.805112386152682
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20741.Liking for watching television,36293,-0.0140409693469458,0.0220776965977158,-0.0573132546784687,0.0292313159845771,0.524810108037274
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20742.Liking for whisky,36293,0.00661786692170424,0.0224018410046332,-0.0372897414473769,0.0505254752907853,0.767684603941751
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20743.Liking for white bread,36293,-0.00616311259490879,0.0216375282714743,-0.0485726680069985,0.0362464428171809,0.775779327627103
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20744.Liking for white rice,36293,-0.0192251125775221,0.0219434613494766,-0.0622342968224963,0.0237840716674521,0.380994303744194
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20745.Liking for white wine,36293,-0.0366470831247011,0.0216760034322189,-0.07913204985185,0.00583788360244789,0.0909427933336411
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,36293,0.0220775104024871,0.0221647677066387,-0.0213654343025247,0.065520455107499,0.319253410448097
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20747.Liking for whole milk,36293,0.0332123699707292,0.0217238280178769,-0.00936633294430947,0.0757910728857678,0.126347437102447
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20748.Liking for wholemeal bread,36293,-0.0165105427353875,0.0229036040599442,-0.0614016066928782,0.0283805212221031,0.471012687275312
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20749.Liking for working up a sweat,36293,-0.00386353122040709,0.0219266373831916,-0.0468397404914626,0.0391126780506484,0.860139785410666
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X21001.Body mass index (BMI),52344,0.0971774875081836,0.0300613232017833,0.0382572940326883,0.156097680983679,0.00122822949202312
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X21002.Weight,52363,-0.037199194319226,0.0161648679091015,-0.0688823354210649,-0.00551605321738701,0.0213870629447547
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X21021.Pulse wave Arterial Stiffness index,37112,0.0202722243222838,0.0104441584334796,-0.000198326207336078,0.0407427748519038,0.052292407592785
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,36094,-0.00664495166239583,0.0236643692555695,-0.053027115403312,0.0397372120785204,0.778872333203791
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,36111,-0.0284979342170368,0.0241050273707426,-0.0757437878636922,0.0187479194296186,0.237151032008387
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,36113,0.000746572497544436,0.0237701454179874,-0.0458429125217108,0.0473360575167997,0.974945075229421
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21040.Satisfaction with bowel habits,36067,-0.0234606789939876,0.0219978658886305,-0.0665764961357033,0.0196551381477281,0.286236112581945
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,36049,-0.00398605538571712,0.0238233001237005,-0.0506797236281701,0.0427076128567359,0.867125164933632
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21042.Greatest number of times bowels opened per day,36067,-0.00814133153074582,0.0234623116161422,-0.0541274622983845,0.0378447992368929,0.728604845128989
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21043.Least number of times bowels opened per week,36001,0.0360590310237949,0.0237345737651421,-0.0104607335558835,0.0825787956034734,0.128743063449641
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21044.Average number of times bowels opened per day,36031,0.00133109474603268,0.0266434221569043,-0.0508900126814997,0.0535522021735651,0.960156042735704
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,36117,0.0178125614096568,0.0238749639970771,-0.0289823680246143,0.064607490843928,0.455646240676234
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,36112,-0.00457028850223399,0.0240567770143784,-0.0517215714504157,0.0425809944459477,0.849330963658659
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32833,-0.012087623034011,0.0421021360183414,-0.09460780962996,0.0704325635619381,0.774050288291211
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,36115,0.0323837341586799,0.0275519067493476,-0.0216180030700414,0.0863854713874012,0.239886439931202
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,36114,0.0472321668788948,0.0361897593725416,-0.0236997614912869,0.118164095249076,0.191893620404498
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,36112,-0.00212184073016986,0.0276053762529528,-0.0562283781859573,0.0519846967256176,0.938734504627215
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,36112,0.0300432911072518,0.0689346484602098,-0.105068619874759,0.165155202089263,0.662978904556886
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,36118,0.0153647170342597,0.0282200542861354,-0.0399465893665657,0.0706760234350851,0.586141862009804
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,36115,0.00840159603026821,0.0260245981617153,-0.0426066163666937,0.0594098084272301,0.746831562581827
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,35956,-0.0362533318512449,0.0250424269049524,-0.0853364885849516,0.0128298248824618,0.147753930642982
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,36108,0.0313926417587044,0.0240045332954495,-0.0156562435003766,0.0784415270177853,0.190991523064066
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,36115,0.0346249419403531,0.0382295242711618,-0.040304925631124,0.10955480951183,0.365119800116646
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,36119,0.0193037953892531,0.0240621418370847,-0.0278580026114328,0.066465593389939,0.422437283767125
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,36118,0.0021717009398993,0.0239975712341166,-0.0448635386789693,0.0492069405587679,0.927895136388199
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X21100.Water hardness (USGS classification),52314,0.0362629508479939,0.0127433190768723,0.0112860454573243,0.0612398562386636,0.00443606709079233
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2139.Age first had sexual intercourse,48498,-0.00374471989278773,0.00739001089816338,-0.018229141253188,0.0107397014676125,0.612351996073486
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2149.Lifetime number of sexual partners,47299,-3.42243940931085e-05,0.0145322941373871,-0.0285175209033719,0.0284490721151857,0.998120963347965
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22032.IPAQ activity group,47284,-0.0100575638246255,0.0145016377828099,-0.0384807738789329,0.0183656462296819,0.487975400198923
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22033.Summed days activity,47792,-0.00662542943053014,0.00726165155749658,-0.0208582664832234,0.00760740762216315,0.361577367776598
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22034.Summed minutes activity,47284,-0.00395854605748139,0.00719492166345283,-0.0180605925178489,0.0101435004028862,0.582198513427432
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22037.MET minutes per week for walking,46297,-0.00914726686901583,0.00770939933780513,-0.0242576895711139,0.00596315583308222,0.235438077976632
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22038.MET minutes per week for moderate activity,47284,-0.000762146949594345,0.00701539871267617,-0.0145123284264396,0.0129880345272509,0.913489912613512
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22039.MET minutes per week for vigorous activity,47284,-0.00963376135434023,0.0144612947212325,-0.0379778990079559,0.0187103762992754,0.505307377153341
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22040.Summed MET minutes per week for all activity,46297,-0.000754717994148568,0.00748208459243871,-0.0154196037953284,0.0139101678070313,0.919654827645206
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X2217.Age started wearing glasses or contact lenses,50466,-0.00347242880347059,0.00608976847458963,-0.0154083750136663,0.00846351740672508,0.568543309906785
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X22501.Year ended full time education,34179,-0.0179287062839639,0.0305291629795617,-0.0777658657239049,0.041908453155977,0.557052397823252
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X22506.Tobacco smoking,34147,0.0452456854831605,0.0563207371952862,-0.0651429594196004,0.155634330385921,0.42180670970065
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,51133,0.110142601189265,0.0477988939606316,0.0164567690264275,0.203828433352103,0.0212155621423946
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23098.Weight,51872,-0.0340462989868024,0.0163686904053313,-0.0661289321812518,-0.00196366579235312,0.0375399694753363
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23099.Body fat percentage,51865,0.11057191272803,0.0155386123910428,0.0801162324415859,0.141027593014474,1.14457804172834e-12
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23100.Whole body fat mass,51849,0.0706630093478708,0.0153313070892991,0.0406136474528445,0.100712371242897,4.06686904230551e-06
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23101.Whole body fat-free mass,51871,-0.0757874754220338,0.0133466500890591,-0.10194690959659,-0.0496280412474779,1.37631422763403e-08
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23102.Whole body water mass,51872,-0.0784070282335565,0.0133865950456063,-0.104644754522945,-0.0521693019441681,4.77434255934339e-09
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23104.Body mass index (BMI),51872,0.0987392756613371,0.0301722464880021,0.0396016725448529,0.157876878777821,0.00106752742816503
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23105.Basal metabolic rate,51872,-0.0741897210599798,0.0142538983023775,-0.10212736173264,-0.0462520803873199,1.95820928018819e-07
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23106.Impedance of whole body,51869,0.0756533735759565,0.0108709815445597,0.0543462497486195,0.0969604974032935,3.51525111116744e-12
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23107.Impedance of leg (right),51872,0.071580232033967,0.00878156973400609,0.0543683553553151,0.088792108712619,3.7884938713196e-16
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23108.Impedance of leg (left),51872,0.0712533492540911,0.00872067638648961,0.0541608235365715,0.0883458749716107,3.22693590714443e-16
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23109.Impedance of arm (right),51869,0.0397386191675887,0.0107450067845562,0.0186784058698585,0.0607988324653188,0.000217531583328689
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23110.Impedance of arm (left),51872,0.0423835289311503,0.0107830713770201,0.0212487090321909,0.0635183488301097,8.49990988534473e-05
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23111.Leg fat percentage (right),51872,0.139314157791736,0.0182838949634947,0.103477723663287,0.175150591920186,2.64617160679288e-14
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23112.Leg fat mass (right),51872,0.0930607504613095,0.0200517233087111,0.0537593727762358,0.132362128146383,3.48607392971372e-06
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23113.Leg fat-free mass (right),51871,-0.0890027032891649,0.0135676957802937,-0.115595387018541,-0.0624100195597893,5.50052233488769e-11
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23114.Leg predicted mass (right),51871,-0.0897580379859409,0.0136533294745319,-0.116518563756023,-0.0629975122158584,5.00202912661022e-11
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23115.Leg fat percentage (left),51869,0.144786101177497,0.0192215083694375,0.107111944773399,0.182460257581594,5.16355525175602e-14
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23116.Leg fat mass (left),51869,0.0928527921136161,0.0210008378406905,0.0516911499458628,0.134014434281369,9.85257113479396e-06
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23117.Leg fat-free mass (left),51868,-0.0869471947941495,0.0142733449201206,-0.114922950837586,-0.0589714387507132,1.13603335406012e-09
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23118.Leg predicted mass (left),51868,-0.0877081067847329,0.0143626704985987,-0.115858940961986,-0.0595572726074794,1.03384591007783e-09
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23119.Arm fat percentage (right),51868,0.0804890637807128,0.0175373757818328,0.0461158072483205,0.114862320313105,4.46534537942257e-06
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23120.Arm fat mass (right),51866,0.0374819198763816,0.0175163928453344,0.00314978989952611,0.0718140498532371,0.032379995134818
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23121.Arm fat-free mass (right),51867,-0.0577446226790192,0.0136345680977372,-0.084468376150584,-0.0310208692074543,2.29285751285608e-05
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23122.Arm predicted mass (right),51867,-0.0586985802702039,0.0136690718833016,-0.0854899611614749,-0.0319071993789328,1.76003421099541e-05
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23123.Arm fat percentage (left),51866,0.0803334371854968,0.0179509388145148,0.0451495971090477,0.115517277261946,7.67233395379678e-06
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23124.Arm fat mass (left),51866,0.0372867833335814,0.0175314019738624,0.00292523546481108,0.0716483312023517,0.0334427414009041
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23125.Arm fat-free mass (left),51866,-0.0513870170846475,0.0139220670258324,-0.0786742684552791,-0.0240997657140159,0.000223855091960814
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23126.Arm predicted mass (left),51864,-0.0574782343753756,0.01392906888573,-0.0847792093914065,-0.0301772593593447,3.69648917274652e-05
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23127.Trunk fat percentage,51863,0.066383928479102,0.0111299179448636,0.0445692893071694,0.0881985676510346,2.49086415529762e-09
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23128.Trunk fat mass,51863,0.0491003938560563,0.0124480538239135,0.0247022083611859,0.0734985793509267,8.02329170528153e-05
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23129.Trunk fat-free mass,51862,-0.060977423816288,0.0120426114311982,-0.0845809422214365,-0.0373739054111395,4.14913405900307e-07
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23130.Trunk predicted mass,51859,-0.0609519423604354,0.0120776900730019,-0.0846242149035192,-0.0372796698173516,4.53087286596547e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23400.Total Cholesterol,42676,0.0621607405583736,0.00851584779970619,0.0454696788709495,0.0788518022457977,3.0518945089921e-13
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,42676,0.0715672110464695,0.00825350192816487,0.0553903472672664,0.0877440748256726,4.76258962156149e-18
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",42676,0.0744669703624571,0.00824479401573038,0.0583071740916255,0.0906267666332886,1.91181249117187e-19
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23403.VLDL Cholesterol,42676,0.0913457913746253,0.00836723896973629,0.0749460029939422,0.107745579755308,1.24658868394895e-27
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23404.Clinical LDL Cholesterol,42676,0.0571103838761171,0.00825184301496622,0.0409367715667833,0.0732839961854509,4.68983257259967e-12
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23405.LDL Cholesterol,42676,0.0665794151544105,0.00828633925699837,0.0503381902106937,0.0828206400981273,1.0144492723203e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23406.HDL Cholesterol,42676,-0.0152016778537738,0.00952833483119523,-0.0338772141229164,0.00347385841536888,0.110642210065501
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23407.Total Triglycerides,42676,0.11121012320153,0.00903585911442779,0.0934998393372515,0.128920407065808,1.26395833617594e-34
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23408.Triglycerides in VLDL,42676,0.104648961954628,0.00900784578878073,0.0869935842086176,0.122304339700638,4.71858150686344e-31
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23409.Triglycerides in LDL,42676,0.123584931430615,0.00895650220335897,0.106030187112032,0.141139675749199,5.11081591812436e-43
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23410.Triglycerides in HDL,42676,0.111495910592948,0.0088459698162987,0.0941578097530027,0.128834011432894,3.20581360044271e-36
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,42676,0.0849663838034385,0.00882118570437034,0.0676768598228727,0.102255907784004,6.88450342220314e-22
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23412.Phospholipids in VLDL,42676,0.104482236267766,0.0086272062017489,0.0875729121123381,0.121391560423194,1.3834707597591e-33
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23413.Phospholipids in LDL,42676,0.0675344395763893,0.00823614854790817,0.0513915884224893,0.0836772907302893,2.62504931675761e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23414.Phospholipids in HDL,42676,0.02490101484958,0.00947278797400886,0.00633435042052261,0.0434676792786373,0.00858118735046559
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23415.Total Esterified Cholesterol,42676,0.0593492852930553,0.00855939887193262,0.0425728635040674,0.0761257070820433,4.28292544929917e-12
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,42676,0.0831470845564904,0.00827558738773542,0.066926933276529,0.0993672358364519,1.14406190641658e-23
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,42676,0.0734769909793822,0.00829280238643164,0.0572230983019762,0.0897308836567882,8.96531425155313e-19
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,42676,-0.0221704519518687,0.00947650894803808,-0.0407444094900233,-0.00359649441371402,0.0193232209720035
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23419.Total Free Cholesterol,42676,0.0679901979082678,0.00841664545007821,0.0514935728261145,0.084486822990421,7.13626339990387e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23420.Free Cholesterol in VLDL,42676,0.100306218884768,0.00853001767617012,0.083587384239475,0.117025053530062,9.05207724691951e-32
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23421.Free Cholesterol in LDL,42676,0.0459677479686526,0.00830984028793964,0.0296804610042909,0.0622550349330143,3.23004113541735e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23422.Free Cholesterol in HDL,42676,0.00855876954080096,0.00963253330722134,-0.0103209957413529,0.0274385348229548,0.374272988836595
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,42676,0.0936003510958192,0.00848414187019885,0.0769714330302294,0.110229269161409,3.51992286554226e-28
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23424.Total Lipids in VLDL,42676,0.107422112006087,0.00874358573212425,0.0902846839711233,0.12455954004105,1.65096655071225e-34
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23425.Total Lipids in LDL,42676,0.0721783080261402,0.00827780608085382,0.0559538081076667,0.0884028079446137,3.11802222998817e-18
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23426.Total Lipids in HDL,42676,0.0161766945349081,0.00952375273270935,-0.0024898608212022,0.0348432498910185,0.0894246161485506
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,42676,0.0583104169059145,0.00897686506899617,0.040715761370682,0.075905072441147,8.55868188654975e-11
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23428.Concentration of VLDL Particles,42676,0.100183335001367,0.00851357593893956,0.0834967261610457,0.116869943841689,8.21485424784748e-32
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23429.Concentration of LDL Particles,42676,0.0670927845679691,0.00821359499357064,0.0509941383805706,0.0831914307553675,3.39848368097114e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23430.Concentration of HDL Particles,42676,0.0483330716291193,0.0089979407096569,0.0306971078381918,0.0659690354200468,7.93501299497553e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,42676,0.0850595637981335,0.00918256245462118,0.067061741387076,0.103057386209191,2.28086333503609e-20
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23432.Average Diameter for LDL Particles,42676,-0.0455842124837108,0.00876911014983687,-0.0627716683773911,-0.0283967565900306,2.04090295451422e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23433.Average Diameter for HDL Particles,42676,-0.0698118759918073,0.00984043911936957,-0.0890991366657716,-0.0505246153178429,1.3641126089109e-12
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23434.Phosphoglycerides,42664,0.086699981375483,0.00899747175594628,0.0690649367338283,0.104335026017138,6.627077988664e-22
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,42664,0.0886098481914987,0.00941151397490905,0.0701632808006769,0.10705641558232,5.48551700195555e-21
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23436.Total Cholines,42664,0.0815513371561882,0.00901018086124688,0.0638913826681443,0.0992112916442321,1.60828555623789e-19
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23437.Phosphatidylcholines,42664,0.0678126633857371,0.00908938819529541,0.0499974625229581,0.0856278642485162,9.13709045511219e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23438.Sphingomyelins,42664,0.0700301819399556,0.00884504594637643,0.0526938918850578,0.0873664719948534,2.61321831800551e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23439.Apolipoprotein B,42676,0.0697595091414721,0.00820872603046728,0.0536704061217563,0.085848612161188,2.12571646024946e-17
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23440.Apolipoprotein A1,42676,0.0330255792302028,0.0092940028512862,0.0148093336416819,0.0512418248187237,0.000381543278938088
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,42676,0.0466667271907027,0.00841977939807835,0.0301639595704691,0.0631694948109363,3.03759633091855e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23442.Total Fatty Acids,42664,0.119749485670955,0.00872548415892297,0.102647536719466,0.136851434622444,1.40790082390064e-42
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23443.Degree of Unsaturation,42664,-0.0727177676726963,0.00890738682125895,-0.0901762458423639,-0.0552592895030288,3.53430703602425e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23444.Omega-3 Fatty Acids,42664,0.0306142956202049,0.00885022906997046,0.0132678466430628,0.047960744597347,0.000543553571310417
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23445.Omega-6 Fatty Acids,42664,0.0864607548297226,0.00862658545314025,0.0695526473415677,0.103368862317878,1.46663800012715e-23
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,42664,0.0816871431010718,0.00874362029712942,0.0645496473186981,0.0988246388834455,1.08672985214832e-20
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,42664,0.131376201871903,0.00893448079530855,0.113864619513098,0.148887784230708,1.43663122583693e-48
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23448.Saturated Fatty Acids,42664,0.123964019602777,0.0087247064235916,0.106863595012537,0.141064444193016,1.73152892126578e-45
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23449.Linoleic Acid,42664,0.0797640073193331,0.00845633839216517,0.0631895840706894,0.0963384305679768,4.65233925331588e-21
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23450.Docosahexaenoic Acid,42664,-0.00381715993824272,0.00884800023441264,-0.0211592403976915,0.013524920521206,0.666173556175861
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,42664,-0.0319839408140487,0.00875847588065988,-0.0491505535401421,-0.0148173280879553,0.000261425709487344
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,42664,-0.106324048727678,0.00939005623261685,-0.124728558943607,-0.0879195385117491,1.37282529361395e-29
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,42664,-0.120361387354197,0.00925075281830475,-0.138492862878074,-0.102229911830319,1.80701856465416e-38
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,42664,0.11047902046365,0.00938026726749559,0.0920936966193583,0.128864344307941,7.27914790354572e-32
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,42664,0.0722906480252152,0.00853353388014059,0.0555649216201396,0.0890163744302908,2.67484089895658e-17
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,42664,-0.0499459314730338,0.00906068812026056,-0.0677048801887445,-0.0321869827573231,3.60529426296127e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,42664,-0.0709346055536677,0.00872968256958722,-0.0880447833900586,-0.0538244277172767,4.83398075819671e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,42664,-0.121444657332181,0.00939015572798126,-0.139849362559025,-0.103039952105338,4.9245487963377e-38
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,42664,0.00259055076908568,0.00867337741456296,-0.0144092689634577,0.0195903705016291,0.765190022165581
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23460.Alanine,42670,0.0779800363986483,0.00852588433887033,0.0612693030944625,0.0946907697028342,6.72741748810869e-20
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23461.Glutamine,42631,-0.137166595996303,0.0084775018139033,-0.153782499551554,-0.120550692441053,2.47849945056894e-58
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23462.Glycine,42660,0.0514397707234616,0.00911750450635777,0.0335694618910003,0.0693100795559228,1.71602491596721e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23463.Histidine,42656,0.0267077324114967,0.00843399376704881,0.010177104628081,0.0432383601949123,0.00154535634281422
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),42666,0.058409444332206,0.00892029755203422,0.0409256611302189,0.0758932275341931,6.04570215730675e-11
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23465.Isoleucine,42672,0.0323008740732691,0.00869369380432037,0.0152612342168012,0.0493405139297371,0.000203672254412942
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23466.Leucine,42672,0.049658846835163,0.00879476369107441,0.0324211100006571,0.0668965836696688,1.67140419540542e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23467.Valine,42666,0.0679105509926743,0.00900385252810669,0.0502630000375852,0.0855581019477635,4.90944963170394e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23468.Phenylalanine,42668,0.0250559481724381,0.00854211915068262,0.00831339463710015,0.041798501707776,0.00336026885761573
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23469.Tyrosine,42659,0.037745542784227,0.0086657221277902,0.0207607274137583,0.0547303581546958,1.33605156353375e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23470.Glucose,42649,-0.0389761089512994,0.00843698760301291,-0.0555126046532047,-0.0224396132493941,3.87913534635051e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23471.Lactate,42651,0.229783288388414,0.00820573799286577,0.213700041922397,0.245866534854431,9.24586563804964e-168
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23472.Pyruvate,42634,0.110062945515608,0.00846943940614275,0.093462844279568,0.126663046751648,2.21526222352244e-38
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23473.Citrate,42673,0.0365231792195257,0.00856273485279065,0.019740218908056,0.0533061395309954,2.00937533077724e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23474.3-Hydroxybutyrate,42452,0.0763902724162749,0.00896199227227496,0.058824767562616,0.0939557772699338,1.70957065539647e-17
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23475.Acetate,42664,-0.123025839372003,0.00834824521720236,-0.139388399997719,-0.106663278746286,8.97455805384322e-49
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23476.Acetoacetate,42674,-0.00409315708544718,0.00864763662214393,-0.0210425248648493,0.0128562106939549,0.635987798857152
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23477.Acetone,42674,-0.0518189480297613,0.00856635049946508,-0.0686089950087129,-0.0350289010508098,1.49487411346966e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23478.Creatinine,42359,0.0173252958364282,0.0095947461284234,-0.00148040657528168,0.0361309982481381,0.0709870229928821
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23479.Albumin,42673,0.0700148100823063,0.00853408864725329,0.0532879963336898,0.0867416238309227,2.53172465477752e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23480.Glycoprotein Acetyls,42676,0.231348224510987,0.00883490157701734,0.214031817420033,0.248664631601941,1.82253389529426e-147
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,42676,0.101797804608523,0.00909195750515234,0.0839775678984249,0.119618041318622,5.69474868996894e-29
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,42676,0.0966743123454797,0.00899620005820022,0.0790417602314073,0.114306864459552,7.93656267558008e-27
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,42676,0.104567693492899,0.00910071768294435,0.0867302868343277,0.12240510015147,2.05071979464435e-30
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,42676,0.109451631301634,0.00901144881980093,0.0917891916148239,0.127114070988444,9.05905107555538e-34
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,42676,0.10992454293968,0.00890179679302716,0.0924770212253464,0.127372064654013,7.64876973984902e-35
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,42676,0.106144629014483,0.00909971695129731,0.0883091837899406,0.123980074239026,2.73200527965956e-31
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,42676,0.0869602668262276,0.00892327842046973,0.0694706411221069,0.104449892530348,2.28940175056539e-22
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,42676,0.109146710315,0.00903586355513954,0.0914364177469267,0.126857002883074,2.02206191493001e-33
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,42676,0.106206449428413,0.00899480791643024,0.0885766259122098,0.123836272944616,5.13137898624385e-32
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,42676,0.105017438615973,0.00896313061530126,0.0874497026099826,0.122585174621964,1.49025299248646e-31
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,42676,0.1045613923378,0.00875530396470471,0.0874009965669783,0.121721788108621,1.03716008240239e-32
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,42676,0.10095881793057,0.00861548784884073,0.0840724617468421,0.117845174114298,1.46109629966579e-31
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,42676,0.104038350842643,0.00889961566899794,0.0865951041314069,0.121481597553879,2.02780779102397e-31
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,42676,0.102774287332472,0.009057042787814,0.0850224834683566,0.120526091196588,1.04139636685103e-29
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,42676,0.10625736430567,0.00892654600895685,0.0887613341281143,0.123753394483225,1.65057356259416e-32
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23496.Total Lipids in Large VLDL,42676,0.102027869147724,0.00888046892225461,0.0846221500601055,0.119433588235344,2.07509845246065e-30
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23497.Phospholipids in Large VLDL,42676,0.106186154322772,0.00891865412187571,0.0887055922438955,0.123666716401648,1.60141457604095e-32
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23498.Cholesterol in Large VLDL,42676,0.104503865507515,0.00873824642030852,0.0873769025237099,0.121630828491319,8.4983207407721e-33
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,42676,0.096922058391013,0.00858853287781321,0.0800885339504992,0.113755582831527,2.10711392622343e-29
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,42676,0.109356202221242,0.00889833549387193,0.0919154646532534,0.126796939789231,1.57805055612316e-34
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23501.Triglycerides in Large VLDL,42676,0.0940603809578636,0.00888107858990659,0.0766534669216466,0.11146729499408,4.15018871990379e-26
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,42676,0.0879491251973365,0.00837434374122012,0.0715354114645451,0.104362838930128,1.06033004887323e-25
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,42676,0.0944468406662801,0.0084632609200511,0.07785884926298,0.11103483206958,8.59149392528312e-29
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,42676,0.085125882016213,0.00834100474158996,0.0687775127226967,0.101474251309729,2.29245883434477e-24
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,42676,0.0564758929985582,0.00820883637559543,0.0403865737023912,0.0725652122947252,6.2542026581881e-12
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,42676,0.0383747872270446,0.00824538821281984,0.0222138263299177,0.0545357481241715,3.28512633786003e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,42676,0.0766940009453723,0.00828697104470393,0.0604515376977526,0.0929364641929921,2.46614561977889e-20
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,42676,0.102414951881728,0.00879318849377861,0.0851803024339216,0.119649601329534,3.34942837674553e-31
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,42676,0.103164821621983,0.00864174300733159,0.0862270053276126,0.120102637916352,1.09641011028902e-32
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23510.Total Lipids in Small VLDL,42676,0.10684916467352,0.00861290235664515,0.0899678760544956,0.123730453292545,3.78434948152699e-35
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23511.Phospholipids in Small VLDL,42676,0.0931559038983293,0.00841390251822558,0.0766646549626072,0.109647152834051,2.28141585434979e-28
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23512.Cholesterol in Small VLDL,42676,0.0866555371130294,0.00833657374520149,0.0703158525724345,0.102995221653624,3.266484068998e-25
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,42676,0.0906891920673901,0.00837713278793013,0.0742700118030471,0.107108372331733,3.3610358238258e-27
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,42676,0.0776058275341084,0.00827860700098763,0.0613797578121727,0.0938318972560442,8.0596837690539e-21
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23515.Triglycerides in Small VLDL,42676,0.108346866639887,0.00895432260338443,0.090796394337253,0.12589733894252,1.57649066694236e-33
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,42676,0.0817159896417408,0.00843605946366551,0.0651813130929565,0.0982506661905252,4.06190079326172e-22
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,42676,0.0808918865111594,0.00851962885425293,0.0641934139568237,0.0975903590654951,2.57283670505716e-21
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,42676,0.0793822821900744,0.00852791116875296,0.0626675762993186,0.0960969880808302,1.49367862092876e-20
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,42676,0.0557562475420014,0.00841743392840586,0.0392580770423259,0.0722544180416769,3.6311139906608e-11
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,42676,0.0482098844573859,0.00842981179969399,0.0316874533299857,0.0647323155847861,1.09442869787223e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,42676,0.0717397272392835,0.00845683976527875,0.0551643212993371,0.0883151331792298,2.42049677662461e-17
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,42676,0.108683685743965,0.00894898259444321,0.0911436798588562,0.126223691629074,9.1728939601377e-34
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23523.Concentration of IDL Particles,42676,0.051636588804179,0.00818121818784758,0.0356014011559977,0.0676717764523603,2.84808983331651e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23524.Total Lipids in IDL,42676,0.0540013309492373,0.00842173811437221,0.0374947242450678,0.0705079376534068,1.48277895732789e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23525.Phospholipids in IDL,42676,0.0518407770808956,0.00844239031831303,0.0352936920570021,0.0683878621047892,8.45546980494068e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23526.Cholesterol in IDL,42676,0.0438288910437255,0.00842059884841467,0.0273245173008327,0.0603332647866182,1.96887065905138e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,42676,0.0431617894553208,0.00842646369106166,0.0266459206208399,0.0596776582898016,3.06205676412254e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23528.Free Cholesterol in IDL,42676,0.0443294696684906,0.00839978820002295,0.0278658847964456,0.0607930545405355,1.33023787104284e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23529.Triglycerides in IDL,42676,0.111331689013503,0.00895304253575517,0.0937837256434227,0.128879652383583,2.63281386630682e-35
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23530.Concentration of Large LDL Particles,42676,0.0570610285669893,0.00821843605081223,0.0409528939073974,0.0731691632265813,4.01282531695289e-12
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23531.Total Lipids in Large LDL,42676,0.0658684532264254,0.00832984646871955,0.0495419541477351,0.0821949523051157,2.82889615669314e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23532.Phospholipids in Large LDL,42676,0.0638957929309761,0.00827066761290399,0.0476852844096843,0.0801063014522679,1.19176431618804e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23533.Cholesterol in Large LDL,42676,0.0592515551942214,0.00834977492965245,0.0428859963321026,0.0756171140563402,1.34654093544187e-12
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,42676,0.0643820273023838,0.00834657572522964,0.0480227388809337,0.0807413157238338,1.30891777097157e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,42676,0.043808496127751,0.00837194636212882,0.0273994812579785,0.0602175109975235,1.69489718312588e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23536.Triglycerides in Large LDL,42676,0.12171321355771,0.00893780545584372,0.104195114864256,0.139231312251164,5.94538952147676e-42
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,42676,0.0817033163694226,0.00825805764416388,0.0655175233868614,0.0978891093519838,5.30622760092312e-23
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23538.Total Lipids in Medium LDL,42676,0.0848490646567474,0.0082953089101732,0.0685902591928079,0.101107870120687,1.81445868356974e-24
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23539.Phospholipids in Medium LDL,42676,0.0798322918756075,0.00828008860877519,0.0636033182024081,0.0960612655488068,6.28645261175639e-22
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23540.Cholesterol in Medium LDL,42676,0.0805602337478124,0.00827996458693619,0.0643315031574175,0.0967889643382074,2.67121982170839e-22
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,42676,0.0885943553617265,0.00831815109054171,0.0722907792242648,0.104897931499188,2.20258592588054e-26
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,42676,0.054874610479594,0.00827074384956897,0.0386639525344389,0.0710852684247492,3.37382547006287e-11
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23543.Triglycerides in Medium LDL,42676,0.124446873180358,0.00897148756659694,0.106862757549828,0.142030988810888,1.8776496631369e-43
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23544.Concentration of Small LDL Particles,42676,0.0745339246199323,0.0082168952618735,0.0584288099066602,0.0906390393332043,1.34270100114123e-19
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23545.Total Lipids in Small LDL,42676,0.0707753269427998,0.00822251143012819,0.0546592045397485,0.086891449345851,8.28614688543798e-18
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23546.Phospholipids in Small LDL,42676,0.0488875980736627,0.00816870583171473,0.0328769346435018,0.0648982615038236,2.22232423041609e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23547.Cholesterol in Small LDL,42676,0.0703454248886141,0.00822106159402274,0.0542321441643295,0.0864587056128987,1.28546572735087e-17
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,42676,0.0824530197502834,0.00826470374784537,0.0662542004045064,0.0986518390960603,2.32695916822126e-23
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,42676,0.0339106467743618,0.00821564392009224,0.017807984690981,0.0500133088577426,3.68821658752532e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23550.Triglycerides in Small LDL,42676,0.118574221431165,0.00902810012117635,0.10087914519366,0.136269297668671,3.66129974533017e-39
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,42676,-0.0479496157903961,0.00944446862302851,-0.066460774291532,-0.0294384572892602,3.88542968498991e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,42676,-0.0683986573928745,0.0094822998567439,-0.0869839651120926,-0.0498133496736565,5.75266148831824e-13
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,42676,-0.0740870364390838,0.00954242325748132,-0.0927901860237472,-0.0553838868544204,8.82297465952312e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,42676,-0.0723646820978994,0.00937572596685838,-0.0907411049929418,-0.053988259202857,1.26160221524146e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,42676,-0.0732984550458586,0.00946791611112326,-0.0918555706236602,-0.054741339468057,1.05003379963305e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,42676,-0.0646244889334979,0.00898331674404983,-0.0822317897518355,-0.0470171881151602,6.63218373349075e-13
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,42676,0.0826420115929891,0.00883661893789992,0.0653222384747052,0.0999617847112729,9.9165179478788e-21
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23558.Concentration of Large HDL Particles,42676,-0.0538723918960634,0.00985252105400511,-0.0731833331619134,-0.0345614506302134,4.63560124643329e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23559.Total Lipids in Large HDL,42676,-0.0525679706055395,0.00986837388530794,-0.0719099834207431,-0.033225957790336,1.0150169877277e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23560.Phospholipids in Large HDL,42676,-0.0436501975153507,0.00986455392266216,-0.0629847232037686,-0.0243156718269329,9.72196274626389e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23561.Cholesterol in Large HDL,42676,-0.0713936411067417,0.00975335652190681,-0.0905102198896791,-0.0522770623238044,2.62193770767735e-13
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,42676,-0.076395935171526,0.00973244998578289,-0.0954715371436604,-0.0573203331993915,4.48691852310854e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,42676,-0.0542042056637102,0.00978257294482119,-0.0733780486355598,-0.0350303626918607,3.06572226925491e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23564.Triglycerides in Large HDL,42676,0.0737082578478588,0.00912188646777394,0.0558293603710219,0.0915871553246957,7.00296760911315e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,42676,0.0296884288169763,0.00922150684927867,0.0116142753923901,0.0477625822415625,0.00128728799965375
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23566.Total Lipids in Medium HDL,42676,0.038295976937718,0.00914679357054626,0.0203682615394473,0.0562236923359887,2.84686589162347e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23567.Phospholipids in Medium HDL,42676,0.0482489606426793,0.00910005600706983,0.0304128508688224,0.0660850704165361,1.16316297916644e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23568.Cholesterol in Medium HDL,42676,0.0101462237948297,0.0091954782657697,-0.00787691360607891,0.0281693611957383,0.269876349892374
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,42676,0.00567559480513978,0.00914822929064175,-0.0122549346045181,0.0236061242147976,0.535002559263587
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,42676,0.0274579503346697,0.00935663361022708,0.00911894845862465,0.0457969522107148,0.0033454413908281
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23571.Triglycerides in Medium HDL,42676,0.111175873115912,0.00880656434868352,0.0939150069924924,0.128436739239332,2.49268428253758e-36
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23572.Concentration of Small HDL Particles,42676,0.0882172145655955,0.0084419551573424,0.0716709824572044,0.104763446673987,1.83582893691371e-25
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23573.Total Lipids in Small HDL,42676,0.103078230073719,0.00849973606351313,0.0864187473892328,0.119737712758204,1.13445385070005e-33
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23574.Phospholipids in Small HDL,42676,0.101103910683089,0.00855486274622405,0.0843363797004902,0.117871441665688,4.52028976266691e-32
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23575.Cholesterol in Small HDL,42676,0.0780557189627976,0.00844219117961228,0.0615090242507575,0.0946024136748377,2.67791857298281e-20
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,42676,0.0672673645579313,0.00840587278846131,0.0507918538925471,0.0837428752233155,1.31909948173855e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,42676,0.10033906481806,0.00863798660578359,0.0834086110707246,0.117269518565396,4.80186812711295e-31
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23578.Triglycerides in Small HDL,42676,0.125297143837109,0.00894875923696494,0.107757575732657,0.14283671194156,3.10833386953769e-44
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42184,0.0394831112125109,0.00868269373480062,0.0224650314923017,0.0565011909327201,5.48209426461178e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42184,0.00245538041656082,0.00895474167870219,-0.0150959132736955,0.0200066741068171,0.783936124987552
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42184,0.01408680604131,0.00885604397793438,-0.00327104015544139,0.0314446522380614,0.111714233006818
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42184,-0.0177085245311928,0.00899061811857136,-0.0353301360435927,-8.69130187929334e-05,0.0488977521074469
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42184,-0.0168465860717849,0.00889152763806853,-0.0342739802423992,0.000580808098829457,0.0581571971303592
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,42554,0.0238303782951052,0.00864236203255912,0.00689134871128935,0.0407694078789211,0.00583436228050819
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,42554,-0.0453184865767342,0.0090569020256741,-0.0630700145470555,-0.027566958606413,5.69403225756248e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,42554,-0.0444537562726915,0.00906851830485845,-0.062228052150214,-0.0266794603951689,9.59865230613236e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,42554,-0.038395960053215,0.00893188820934591,-0.055902460943533,-0.0208894591628971,1.72980935679485e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,42554,0.0320648734707214,0.00888438593407555,0.0146514770399333,0.0494782699015095,0.000308352742698988
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,42675,0.0764832741959064,0.00878062121776033,0.0592732566090961,0.0936932917827166,3.3753773823769e-18
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,42675,0.00123618058401279,0.00856503007725876,-0.0155512783674144,0.01802363953544,0.885242988167027
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,42675,-0.018804899921107,0.00881431371952804,-0.036080954811382,-0.00152884503083205,0.0329058094503032
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,42675,0.0492900905310592,0.00844406263139152,0.0327397277735318,0.0658404532885866,5.4290674579068e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,42675,-0.0308424972174118,0.00841331919626703,-0.0473326028420951,-0.0143523915927284,0.000247404274499273
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,42676,-0.00617650752609033,0.00856264529471861,-0.0229592923037388,0.0106062772515581,0.470717963348391
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,42676,-0.0365320260885545,0.00888610206282751,-0.0539487861316965,-0.0191152660454126,3.96039573343527e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,42676,-0.0419724051569676,0.00897996615436558,-0.0595731388195241,-0.024371671494411,2.98242589252368e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,42676,-0.0216960712394361,0.00867034198964821,-0.0386899415391466,-0.00470220093972558,0.0123495743292537
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,42676,0.0300512290652253,0.00880677494792397,0.0127899501672943,0.0473125079631563,0.000646098954523216
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,42676,-0.0322622173453204,0.00885501205287973,-0.0496180409689647,-0.0149063937216761,0.000270085831292833
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,42676,-0.0153999310404936,0.00863192315674806,-0.0323185004277198,0.00151863834673256,0.0744352283304312
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,42676,-0.00113031308683543,0.00846527417933482,-0.0177222504783317,0.0154616243046608,0.893781368577139
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,42676,-0.0342535720396637,0.00888927329670537,-0.0516765477012062,-0.0168305963781211,0.000117047748194254
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,42676,0.0206358605496516,0.00870789013578209,0.00356839588351866,0.0377033252157844,0.0178122446907155
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,42676,-0.00288477268064896,0.00867074408657562,-0.0198794310903372,0.0141098857290393,0.739364518674753
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,42676,-0.0432155071670522,0.00896554651541566,-0.0607879783372669,-0.0256430359968375,1.44996124727979e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,42676,-0.0449371041086646,0.00903999344851349,-0.0626554912677511,-0.0272187169495782,6.74537951630303e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,42676,-0.0200915543549617,0.00849763336997726,-0.0367469157601171,-0.0034361929498063,0.0180748257552281
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,42676,0.0487332173229252,0.00892784374743858,0.0312346435779456,0.0662317910679049,4.88484960908912e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,42676,-0.0278918407773431,0.00816435379947651,-0.043893974224317,-0.0118897073303691,0.000636667527411555
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,42676,-0.0247056910789307,0.0086447910676283,-0.0416494815714821,-0.00776190058637921,0.00427147967417271
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,42676,-0.0250835551094427,0.00863016212360264,-0.0419986728717039,-0.00816843734718157,0.00366093516750004
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,42676,-0.0124342426472365,0.00831798383462086,-0.0287374909630934,0.00386900566862035,0.134973718675108
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,42676,0.0444078461458552,0.00891615799127675,0.0269321764829528,0.0618835158087577,6.4170938314479e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,42676,-0.0239525153834871,0.00828918127495321,-0.0401993106823954,-0.00770572008457881,0.00386332805999051
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,42676,-0.0371980527923921,0.00895930430844824,-0.0547582892369507,-0.0196378163478336,3.31767794983083e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,42676,0.0180102015359452,0.008356723279199,0.00163102390871521,0.0343893791631753,0.0311657858381923
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,42676,-0.0660422403957856,0.00894762207854796,-0.0835795796697396,-0.0485049011218316,1.66323555442209e-13
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,42676,0.0421556386032252,0.00893737374229023,0.0246383860683364,0.0596728911381141,2.42007877033131e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,42676,-0.0618354965746765,0.00848309310255931,-0.0784623590556928,-0.0452086340936602,3.29001133480476e-13
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,42676,0.00362554909696931,0.00827813452151146,-0.0125995945651932,0.0198506927591318,0.661417278458756
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,42676,0.0754711174422472,0.00853191188817739,0.0587485701414195,0.0921936647430749,1.02099562216657e-18
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,42676,-0.0845717872350476,0.00912640746231779,-0.10245954586119,-0.0666840286089047,2.20670811101869e-20
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,42676,0.031508277025378,0.00878027809485002,0.0142989319594719,0.048717622091284,0.000333728867239101
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,42676,-0.111695239852348,0.00832898387204693,-0.12802004824156,-0.0953704314631358,9.58256997178696e-41
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,42676,0.043676350013267,0.00844093317408804,0.0271321209920544,0.0602205790344795,2.3198768671086e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,42676,0.102558615773396,0.00834472704214614,0.0862029507707897,0.118914280776003,1.56425099335692e-34
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,42676,-0.070056645132065,0.00895854562336939,-0.087615394553869,-0.052497895710261,5.6690843691239e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,42676,0.0666155947312807,0.00895113672395923,0.0490713667523206,0.0841598227102408,1.05064412814065e-13
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,42667,-0.0822485404585578,0.00931392338399786,-0.100503830291194,-0.0639932506259219,1.16723562035778e-18
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,42667,0.00591629174378059,0.00883565093106636,-0.0114015840811095,0.0232341675686707,0.503128627331379
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,42667,-0.0162527329152875,0.00857859726870178,-0.033066783561943,0.000561317731367975,0.0581710958436456
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,42667,0.0537777096979647,0.00975968935374072,0.0346487185646329,0.0729067008312965,3.6503371569843e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,42667,0.119514851002256,0.00925592047681202,0.101373246867705,0.137656455136808,6.44204416271381e-38
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,42676,0.0829760233684649,0.00906334751699358,0.0652118622351574,0.100740184501772,6.20103630903922e-20
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,42676,-0.107202794330102,0.00932859125080238,-0.125486833181675,-0.0889187554785295,2.00875868919405e-30
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,42676,-0.111284506616698,0.00939111133476977,-0.129691084832847,-0.0928779284005495,3.11070105889713e-32
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,42676,-0.0370690146619199,0.00889377218166751,-0.0545008081379882,-0.0196372211858516,3.09236732402544e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,42676,0.102226671032244,0.00921818607584155,0.0841590263235947,0.120294315740894,1.869107625562e-28
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,42676,0.0582496595563945,0.00920107678128535,0.0402155490650752,0.0762837700477138,2.51713271919942e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,42676,-0.0826411881614649,0.00910181213256418,-0.100480739941291,-0.0648016363816392,1.23876166713274e-19
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,42676,-0.0894780385731521,0.00904450674691059,-0.107205271797097,-0.0717508053492074,5.3425744478084e-23
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,42676,-0.00909531585414321,0.00956407537794249,-0.0278409035949105,0.00965027188662408,0.341627783754617
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,42676,0.0923987290070228,0.00897007937372298,0.0748173734345257,0.10998008457952,8.63695797673132e-25
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,42676,-0.00665613966113522,0.00883216995676652,-0.0239671927763976,0.0106549134541272,0.451087889723141
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,42676,-0.052902272920338,0.00881017546410563,-0.070170216829985,-0.0356343290106909,1.9663994275436e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,42676,-0.0518670307018173,0.00890062356321326,-0.0693122528857153,-0.0344218085179193,5.7601747545024e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,42676,0.00195358507475426,0.00881063012870317,-0.015315249977504,0.0192224201270125,0.82452707458011
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,42676,0.0904338427369516,0.00906218928961742,0.0726719517293014,0.108195733744602,2.26440530757966e-23
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,52167,0.00655906047407825,0.00736418951666579,-0.0078747509785867,0.0209928719267432,0.373115721623586
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,52167,-0.000842740632701278,0.00716984405790014,-0.0148956349861856,0.013210153720783,0.906433489477094
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50706,0.0111463840895241,0.00682511082131483,-0.00223083312025295,0.0245236012993012,0.102453493945797
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50706,-0.00454173791415525,0.00750292976756322,-0.0192474802585791,0.0101640044302687,0.54496707269527
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50706,0.0171487034781599,0.00731347861552012,0.00281428539174045,0.0314831215645793,0.0190459189339312
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50706,0.00970276812361523,0.00667040589436184,-0.00337122742933397,0.0227767636765644,0.145794799448794
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24009.Traffic intensity on the nearest road,52167,-0.0227117478405141,0.0281262717938159,-0.0778392405563932,0.032415744875365,0.419391271008402
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24010.Inverse distance to the nearest road,52167,-0.00391763857815254,0.00643552622331521,-0.0165312699758504,0.00869599281954527,0.542694943864523
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24011.Traffic intensity on the nearest major road,52167,0.0120872579135643,0.0063508315684191,-0.000360371960537157,0.0245348877876657,0.0570196433314505
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24012.Inverse distance to the nearest major road,52167,0.00324212438416867,0.00647254813969766,-0.00944406996963875,0.0159283187379761,0.616443580822278
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24013.Total traffic load on major roads,52167,-0.01798869654128,0.0197610084975902,-0.0567202731965568,0.0207428801139968,0.362667186220069
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24015.Sum of road length of major roads within 100m,52167,-0.00430519226832311,0.0191895612525798,-0.0419167323233795,0.0333063477867333,0.822486392706437
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,52167,0.0139262869427683,0.00731731721267601,-0.000415654794076728,0.0282682286796132,0.0570274958055009
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,52167,0.0096346959837777,0.00730204065724256,-0.00467730370441771,0.0239466956719731,0.187031021221831
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,52167,0.0132725450633709,0.00721959378285363,-0.000877858751022201,0.027422948877764,0.0660154926548303
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,52113,0.0262742848787377,0.00720506395102457,0.0121523595347295,0.0403962102227458,0.000266278475828071
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24020.Average daytime sound level of noise pollution,52167,0.00024983679306301,0.00646528484870587,-0.0124221215104005,0.0129217950965265,0.969175503749357
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24021.Average evening sound level of noise pollution,52167,0.00035883856890433,0.00646665591188002,-0.0123158070183805,0.0130334841561892,0.955748106949316
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24022.Average night-time sound level of noise pollution,52167,0.00023042069822725,0.00646529789819042,-0.012441563182226,0.0129024045786805,0.971570033485686
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,52167,0.000300455525073839,0.00646554279024968,-0.0123720083438155,0.0129729193939632,0.962935832778761
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,52167,0.00031338090811593,0.00646543601165003,-0.0123588736747181,0.01298563549095,0.961341943260881
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2405.Number of children fathered,40134,0.0225024756792969,0.022141278858721,-0.0208944308837962,0.06589938224239,0.309502703239327
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",49875,-0.0121825311133722,0.00748639644093745,-0.0268558681376096,0.00249080591086519,0.103690951816484
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",49875,0.00434277253651154,0.00672109633951077,-0.00883057628892958,0.0175161213619527,0.518195539614001
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24502.Water percentage, buffer 1000m",49875,-0.0150366097420752,0.00682373255536117,-0.0284111255505831,-0.00166209393356729,0.0275651939578385
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",49875,-0.0060901930399719,0.00701183811922565,-0.0198333957536542,0.00765300967371036,0.385098628319148
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",49875,0.0017901123533437,0.00675203099703904,-0.0114438684008528,0.0150240931075402,0.790918077724599
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24505.Water percentage, buffer 300m",49875,-0.0153579967486323,0.00687903429136201,-0.0288409039597018,-0.00187508953756272,0.0255872927705487
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",52314,-0.0204990964541596,0.00721396492533454,-0.0346384677078153,-0.00635972520050386,0.00449291100107136
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",52314,-0.0151315673686359,0.00674212978369893,-0.0283461417446858,-0.00191699299258601,0.0248205658609567
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24508.Distance (Euclidean) to coast,52314,0.0503260291316855,0.00636114136554839,0.0378581920552106,0.0627938662081603,2.65693756443007e-15
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,35572,0.0122422343522664,0.0261990032724857,-0.0391078120618056,0.0635922807663384,0.640316506958084
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2704.Years since last cervical smear test,38495,-0.00509127072726721,0.0224210739500203,-0.0490365756693071,0.0388540342147726,0.820370228122019
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2714.Age when periods started (menarche),40961,0.0376086438570007,0.0179374025989102,0.00245133476313666,0.0727659529508647,0.0360449320905748
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2734.Number of live births,41314,0.0176420263695976,0.0174239037596429,-0.0165088249993024,0.0517928777384977,0.311310389606484
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2744.Birth weight of first child,39464,-0.0156479451229253,0.0186177244104487,-0.0521386849674048,0.0208427947215542,0.400655277020836
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2754.Age at first live birth,38232,0.00121862393633779,0.0115464505464264,-0.0214124191346579,0.0238496670073335,0.915948880287179
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2764.Age at last live birth,38202,0.0127848036025125,0.0106238624738805,-0.00803796684629338,0.0336075740513183,0.228851459598427
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2794.Age started oral contraceptive pill,37129,0.0157185379050024,0.0166612959181958,-0.0169376020946615,0.0483746779046662,0.345496735510256
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2804.Age when last used oral contraceptive pill,36335,0.00674606262649259,0.0125691024060712,-0.017889378089407,0.0313815033423922,0.591479186792753
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2867.Age started smoking in former smokers,36280,-0.00783483342128677,0.0120986044614159,-0.0315480981656618,0.0158784313230883,0.517276589085366
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",36100,0.0408066107674862,0.0297082264481102,-0.0174215130708098,0.0990347346057822,0.169616864515987
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,36096,0.0398912155951453,0.0325356066981057,-0.023878573533142,0.103661004723432,0.220210887942367
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,36114,0.0672775117938858,0.0339213658222234,0.00079163478232791,0.133763388805444,0.0473692342736611
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",36086,0.0414168368334641,0.0331908276295833,-0.0236371853205192,0.106470858987447,0.212132124105609
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28739.Difficulty with standing for long periods,36120,-0.0169314935497459,0.0252463804733904,-0.0664143992775911,0.0325514121780992,0.502465679915105
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28740.Difficulty with taking care of household responsibilities,36142,-0.00231504023860486,0.0282022112792105,-0.0575913743458575,0.0529612938686478,0.934579746221028
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28741.Difficulty learning a new task,36082,0.032173579136196,0.0323021052599826,-0.0311385471733698,0.0954857054457618,0.319274885648415
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28742.Difficulty with joining in community activities,35813,-0.0018508975517793,0.0347151054442832,-0.0698925042225743,0.0661907091190157,0.957481122467408
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28743.Difficulty with being emotionally affected by health problems,36098,0.0312301674765086,0.0290459044633649,-0.0256998052716866,0.0881601402247039,0.282322615477847
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,36144,0.041132876190492,0.044750559607569,-0.0465782206403432,0.128843973021327,0.358044365513374
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,35796,0.0155232123445276,0.0253269633637846,-0.0341176358484903,0.0651640605375454,0.539955311910736
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2897.Age stopped smoking,36279,0.0253118101967395,0.0113996464296825,0.00296850319456175,0.0476551171989172,0.0264229289545985
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35404,-0.0387330059505845,0.0272854671795294,-0.0922125216224622,0.0147465097212932,0.155789767607456
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35404,0.0856945383233595,0.0306825476223503,0.0255567449835529,0.145832331663166,0.00523911412373867
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35404,0.10046175090377,0.10004351040011,-0.095623529480446,0.296547031287986,0.315330703639325
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35404,-0.066961032064073,0.117864295590784,-0.29797505142201,0.164052987293864,0.569974210454922
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35404,-0.154208288988113,0.142990216439673,-0.434469113209873,0.126052535233647,0.280873342580748
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35404,-0.00869627756083264,0.120664785278176,-0.245199256706057,0.227806701584392,0.942548742579231
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35404,-0.0246257779681296,0.0496894417923045,-0.122017083881046,0.0727655279447874,0.620198583482206
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35404,0.0577102853693873,0.0848980080304657,-0.108689810370325,0.2241103811091,0.49668166022383
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29002.Recent lack of interest or pleasure in doing things,35359,0.00727133755004079,0.0347260236886594,-0.0607916688797316,0.0753343439798132,0.834149472921106
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29003.Recent feelings of depression,35348,-0.0131886896611618,0.0337956507858866,-0.0794281652014996,0.053050785879176,0.696366582690962
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35363,0.00819359619547103,0.0263815102769135,-0.0435141639472794,0.0599013563382215,0.756129658862553
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29005.Recent feelings of tiredness or low energy,35365,0.00179747099292862,0.0260245862639294,-0.049210718084373,0.0528056600702303,0.944937582106267
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29006.Recent poor appetite or overeating,35376,0.0646228819599116,0.0408869897802295,-0.0155156180093383,0.144761381929161,0.114038016158423
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29007.Recent feelings of inadequacy,35342,-0.0106543765470274,0.0381417027699001,-0.0854121139760316,0.0641033608819769,0.779995860299607
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29008.Recent trouble concentrating on things,35375,0.0178452140765815,0.0368746839818,-0.0544291665277466,0.0901195946809096,0.628444071554199
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35367,0.140033824195463,0.0631417140791937,0.0162760646002432,0.263791583790682,0.0266067737501992
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29010.Recent thoughts of suicide or self-harm,35347,-0.0181796611244039,0.0710355384053089,-0.157409316398809,0.121049994150002,0.798018493284826
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29038#0.Substances taken for depression_None of options listed,36403,0.0154127729218735,0.0533726550072472,-0.0891976308923309,0.120023176736078,0.772760656342132
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),36403,0.113017799451977,0.138844491420658,-0.159117403732512,0.385153002636466,0.415678506292018
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),36403,-0.00277364584544569,0.0555790862717725,-0.11170865493812,0.106161363247228,0.960199883369316
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),36403,-0.20370874889777,0.168784350831683,-0.534526076527869,0.127108578732328,0.227503604457039
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),36403,0.0813752769764997,0.144731720291753,-0.202298894795336,0.365049448748335,0.573963805634204
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),36403,0.0012552911944945,0.149733795984854,-0.292222948935819,0.294733531324808,0.993311256216713
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),36403,-0.157039044456561,0.159504673537288,-0.469668204589646,0.155590115676523,0.324882150481013
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),36403,0.160455165450865,0.149816803104915,-0.133185768634769,0.4540960995365,0.284201174646245
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),36403,0.0432716236120628,0.0975466772617432,-0.147919863820954,0.234463111045079,0.657345729583024
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,36403,-0.0069440071576143,0.049269569366296,-0.103512363115555,0.089624348800326,0.887922016682421
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,36403,0.0159943349782423,0.0888463314010941,-0.158144474567902,0.190133144524387,0.857139997011294
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,36403,-0.0295131124796179,0.134762561669634,-0.293647733352101,0.234621508392865,0.826655603146634
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,36403,-0.143787106948482,0.193666967966661,-0.523374364163137,0.235800150266173,0.45784184428294
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,36403,-0.0241299591868757,0.13098384860639,-0.2808583024554,0.232598384081648,0.853845365502502
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,36403,0.140802633086979,0.183122299599869,-0.218117074128765,0.499722340302723,0.441978200550978
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,36403,-0.0901502469469519,0.183251069618979,-0.44932234340015,0.269021849506246,0.622770120142092
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,36403,-0.130255907202678,0.106960095568533,-0.339897694517003,0.0793858801116468,0.22334018721547
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,36403,-0.0209499680634945,0.0989728823280145,-0.214936817426403,0.173036881299414,0.83236749772883
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,36403,-0.286824991400486,0.140005547512275,-0.561235864524546,-0.0124141182764266,0.0405306480353904
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29058.Recent feelings or nervousness or anxiety,35268,0.0103153443910598,0.0312172574191859,-0.0508704801505446,0.0715011689326642,0.74108100708317
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29059.Recent inability to stop or control worrying,35282,0.0446074237530635,0.0319734780259248,-0.0180605931777491,0.107275440683876,0.163025046528372
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29060.Recent worrying too much about different things,35280,0.0223989526672542,0.0295537669262277,-0.0355264305081521,0.0803243358426606,0.448537111368623
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29061.Recent trouble relaxing,35276,0.0560283177262384,0.0319819808555599,-0.00665636475065894,0.118713000203136,0.0798463349580072
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29062.Recent restlessness,35292,0.0673864243444549,0.0470252607245564,-0.0247830866756757,0.159555935364585,0.151913823031287
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29063.Recent easy annoyance or irritability,35263,0.0115545651888419,0.0326835892290874,-0.0525052697001694,0.0756144000778532,0.723704896075323
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29064.Recent feelings of foreboding,35264,0.040045027707407,0.0369536933475704,-0.032384211253831,0.112474266668645,0.278561172863014
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,36403,-0.0631239110634695,0.06198335565253,-0.184611288142428,0.0583634660154893,0.308521605289851
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,36403,-0.0635950378611021,0.110977008092189,-0.281109973721792,0.153919897999588,0.5666307670221
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',36403,-0.0915790882416974,0.136116334031459,-0.358367102943356,0.175208926459962,0.50109601535519
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,36403,-0.168378633072798,0.126451262692905,-0.416223107950892,0.0794658418052966,0.183043824361749
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#2.Symptoms of panic attack_Sweating,36403,-0.0236685138401229,0.095341279535864,-0.210537421730416,0.163200394050171,0.803947719088247
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,36403,0.0454036364493989,0.100650866653087,-0.151872062190652,0.24267933508945,0.651930827561177
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,36403,0.0330160970362684,0.100619251654478,-0.164197636206509,0.230229830279045,0.742823637870199
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,36403,0.0697050773135385,0.102239454581094,-0.130684253665405,0.270094408292482,0.495398354450611
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,36403,-0.0826478739408375,0.129992778886031,-0.337433720557459,0.172137972675784,0.524934666513136
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29076.Felt loved as a child,35263,0.00798603973807182,0.0272882440780342,-0.0454989186548751,0.0614709981310188,0.769795916240409
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29077.Physically abused by family as a child,35283,-0.06113015921715,0.0405810087229768,-0.140668936314185,0.0184086178798845,0.132023199371708
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29078.Felt hated by family member as a child,35268,0.0660237323997022,0.0403246998224195,-0.0130126792522399,0.145060144051644,0.101619103281536
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29079.Sexually molested as a child,35225,0.00740937327157149,0.0517790599847772,-0.0940775842985918,0.108896330841735,0.886219193985503
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29080.Someone to take to doctor when needed as a child,35243,-0.0524148773294914,0.0376250329421702,-0.126159941896145,0.0213301872371622,0.163645237745949
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35274,0.0703272265370892,0.0593952340276668,-0.0460874321571377,0.186741885231316,0.236437568657367
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,35228,0.0321334235289797,0.0445056757793901,-0.055097700998625,0.119364548056584,0.470317962095481
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35281,-0.00431592040224549,0.0517578303356656,-0.10576126786015,0.097129427055659,0.933546717927805
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,35268,0.0110014463272342,0.0709940278531093,-0.12814684826486,0.150149740919328,0.87685564981573
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,35269,-0.128129927137962,0.0658089340890184,-0.257115437952438,0.000855583676514116,0.0515808878147809
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29086.Experienced a violent or sexual assault,35282,-0.0650724256737158,0.0626980380755711,-0.187960580301835,0.0578157289544036,0.299371712051346
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29087.Experienced a life-threatening injury or illness,35276,-0.0386219705444554,0.0300719905519937,-0.097563072026363,0.0203191309374523,0.19907996537535
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29088.Experienced a marital separation or divorce,35282,0.0298423642264227,0.0305962017674185,-0.0301261912377176,0.0898109196905629,0.329419620356963
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29089.Experienced the death of a spouse or partner,35289,-0.0413365210517987,0.0328498613634974,-0.105722249324254,0.0230492072206562,0.20831453623248
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35280,-0.0412184542061286,0.0389647875586873,-0.117589437821156,0.0351525294088985,0.29017104799651
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29091.Frequency of drinking alcohol,35280,-0.02535011520454,0.0242938937271177,-0.0729661469096907,0.0222659165006107,0.296768972712838
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,34527,-0.0383291513644505,0.0302502947593247,-0.0976197290927268,0.0209614263638259,0.205186680323947
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,34552,-0.0398688883113019,0.0314007525251762,-0.101414363260647,0.0216765866380435,0.204254029379513
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29104.Ever used cannabis,35281,-0.0604720354859201,0.0457071047922735,-0.150057960878776,0.029113889906936,0.185873925081362
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29108.Ever thought that life not worth living,35247,0.026427169717239,0.0336491027564027,-0.0395250716853102,0.0923794111197882,0.432264380118217
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29109.Ever contemplated self-harm,35272,0.00835784511040956,0.050761954259024,-0.0911355852372775,0.107851275458097,0.869226665917383
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29111.Ever self-harmed,35280,-0.0231184854610968,0.0897632607674514,-0.199054476565301,0.152817505643108,0.796763295236625
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35270,-0.0063359121911447,0.0508218075798624,-0.105946655047675,0.0932748306653857,0.900789596436637
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,37032,0.109037075878158,0.148770033307053,-0.182552189403665,0.400626341159982,0.463626915425704
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,37032,-0.0270868009901826,0.110642970490678,-0.243947023151911,0.189773421171546,0.806607892012791
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,37032,0.236801271532964,0.129736222944378,-0.017481725438017,0.491084268503945,0.0680010810512522
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,37032,-0.0934637658873242,0.193365654632731,-0.472460448967477,0.285532917192829,0.628858995009522
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35261,-0.0219006341425828,0.0283864137548114,-0.077538005102013,0.0337367368168475,0.440429906053401
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X29153.Pain or discomfort today,35272,0.0257271034423394,0.025721003471593,-0.0246860633619829,0.0761402702466617,0.317235588717712
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29154.Anxiety or depression today,35272,0.0328909164014839,0.0334996755243536,-0.0327684476262491,0.098550280429217,0.326223734587444
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29166.Frequency of confiding in someone close,35088,0.0502907770240332,0.0254830737960513,0.000343952383772675,0.100237601664294,0.0484856030149815
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35253,0.00615275207636848,0.0264722474593292,-0.0457328529439167,0.0580383570966537,0.81621754466713
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35253,-0.00635966794362765,0.0270725834344007,-0.0594219314750529,0.0467025955877976,0.814285167937251
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35253,0.0404270616614585,0.0338406386377678,-0.0259005900685663,0.106754713391483,0.232278158723845
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35253,-0.00896159652486758,0.0313081996335839,-0.070325667806692,0.0524024747569568,0.77470562504692
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35253,0.00770853913106142,0.053790119364082,-0.0977200948225392,0.113137173084662,0.886051928020066
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35253,-0.0226754473824221,0.0255856985226845,-0.0728234164868837,0.0274725217220396,0.375515428564914
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35251,-0.0347868698049594,0.0274973177406721,-0.0886816125766768,0.019107872966758,0.205883979588275
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35251,0.0253888118317975,0.0423507616057772,-0.0576186809155259,0.108396304579121,0.548869327562007
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35251,0.0552449394241143,0.0618217405359937,-0.0659256720264334,0.176415550874662,0.371562514959228
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35251,0.112019472770249,0.0492763501337239,0.0154378265081499,0.208601119032347,0.0230435219994015
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35251,0.0887546137923579,0.0823146100208682,-0.0725820218485437,0.250091249433259,0.280971182086843
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35251,0.0279189348073789,0.0373354121100829,-0.0452584729283835,0.101096342543141,0.454617691679708
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29171.Frequency of feeling 'in tune' with people,35151,0.0536521556719303,0.0328127471519827,-0.0106608287459558,0.117965140089816,0.102080720423545
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29172.Freuency of feeling that lacks companionship,35233,-0.0192049569659821,0.0295930386202501,-0.0772073126616722,0.038797398729708,0.516383264581547
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29173.Frequency of feeling left out,35190,0.0174852741825264,0.031492816086964,-0.0442406453479232,0.0792111937129759,0.578768536409398
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29174.Frequency of feeling isolated from others,35225,0.0225679266812173,0.0325662176530419,-0.0412618599187449,0.0863977132811795,0.488345145725948
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29175.Tendency to bounce back quickly after hard times,35267,0.0246181368301744,0.0257836022867087,-0.0259177236517747,0.0751539973121235,0.339717783930635
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29176.Ability to make it through stressful events,35267,-0.030144484404055,0.024764166021195,-0.0786822498055972,0.0183932809974872,0.223551774401864
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29177.Quick recovery from stressful events,35267,0.00847101642855753,0.0255496833866823,-0.0416063630093398,0.0585483958664548,0.740239967306823
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29178.Hard to snap back when something bad happens,35267,-0.00883150234398427,0.0249661447903346,-0.0577651461330402,0.0401021414450716,0.723546680092938
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29179.Comes through difficult times with little trouble,35267,0.0491418874635892,0.0254705639652932,-0.000780417908385504,0.099064192835564,0.0537327412163039
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29180.Tendency to take a long time to get over setbacks,35267,-0.0010329028637546,0.0250714921570584,-0.0501730274915892,0.0481072217640799,0.967139163629456
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29181.General happiness,35236,-0.00145586932341934,0.0261246024231846,-0.0526600900728613,0.0497483514260226,0.95556041407974
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29182.Belief that own life is meaningful,35148,-0.0148149899352066,0.0261193936898224,-0.0660090015672585,0.0363790216968453,0.57059788590604
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,35606,0.0119527039906934,0.0238590118071688,-0.0348109591513574,0.0587163671327443,0.616407815084743
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2946.Father's age,30171,-0.0404825394825362,0.059986277154238,-0.158055642704843,0.0770905637397703,0.499922259720305
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2966.Age high blood pressure diagnosed,36825,0.0121100445238455,0.0121440415029642,-0.0116922768219645,0.0359123658696554,0.318698806715494
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30000.White blood cell (leukocyte) count,51706,0.118390972350203,0.00693743522657669,0.104793599306112,0.131988345394293,6.86185458769804e-65
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51706,0.000764292033818447,0.00733726385121182,-0.0136167451145567,0.0151453291821936,0.917038693768797
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30020.Haemoglobin concentration,51706,-0.0421294109126101,0.00787252043115072,-0.0575595509576655,-0.0266992708675547,8.81043879424854e-08
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30030.Haematocrit percentage,51706,-0.0188762452182943,0.00766232804245741,-0.0338944081815108,-0.00385808225507775,0.0137657110903494
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30040.Mean corpuscular volume,51706,-0.0253388970638764,0.00673370467028143,-0.038536958217628,-0.0121408359101248,0.000168316389891748
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51706,-0.0466167061869324,0.0067476174999957,-0.059842036486924,-0.0333913758869409,5.02448662006602e-12
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51706,-0.050875499675033,0.0065994515341326,-0.0638104246819329,-0.0379405746681331,1.31992071114266e-14
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51706,0.0295615765582034,0.00681875466096389,0.0161968174227142,0.0429263356936926,1.46170800029476e-05
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30080.Platelet count,51706,0.347793563245249,0.00626585471854972,0.335512487996892,0.360074638493607,0
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30090.Platelet crit,51706,0.312972984146026,0.00647244453422656,0.300286992858942,0.32565897543311,0
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51706,-0.154145766803262,0.00629295568539049,-0.166479959946627,-0.141811573659897,8.60494767559689e-131
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30110.Platelet distribution width,51706,-0.0968031198443816,0.00659109941087601,-0.109721674689699,-0.0838845649990646,1.31226981609767e-48
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30120.Lymphocyte count,51669,0.0484038240780597,0.00656774414782956,0.0355310455483138,0.0612766026078056,1.76613074647952e-13
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30130.Monocyte count,51669,0.0560920789974555,0.00671301717035235,0.0429345653435649,0.0692495926513461,6.87577601779713e-17
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30140.Neutrophill count,51669,0.107772526924621,0.00687926502706929,0.0942891674715655,0.121255886377677,5.02903059587185e-55
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30150.Eosinophill count,51669,0.0458014107357314,0.00658006772578421,0.0329044779931944,0.0586983434782685,3.48076842699283e-12
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30160.Basophill count,51669,0.112611288338005,0.0140860084693701,0.0850027117380397,0.140219864937971,1.36274786907813e-15
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30170.Nucleated red blood cell count,51669,-0.0883504186653554,0.0707360741699612,-0.226993124038479,0.0502922867077685,0.211672591680893
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30180.Lymphocyte percentage,51669,-0.0397441252963748,0.00655091309720146,-0.0525839149668897,-0.02690433562586,1.32438609124669e-09
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30190.Monocyte percentage,51669,-0.0216074980796508,0.00663541722830246,-0.0346129158471236,-0.00860208031217797,0.00113006273183451
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30200.Neutrophill percentage,51669,0.0378492473050709,0.00650038119791545,0.0251085001571566,0.0505899944529852,5.87206967606046e-09
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30210.Eosinophill percentage,51669,0.0108921585570725,0.00654137264035864,-0.00192893181803045,0.0237132489321754,0.0959031167859067
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30220.Basophill percentage,51669,-0.0185848469661,0.00652353841397339,-0.0313709822574879,-0.00579871167471216,0.00439118134610984
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30230.Nucleated red blood cell percentage,51669,-0.0887473994413025,0.0707293738282917,-0.227376972144754,0.0498821732621492,0.209584026523715
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30240.Reticulocyte percentage,51318,0.041701246471689,0.00705227396860911,0.0278787894932151,0.0555237034501629,3.40528721535918e-09
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30250.Reticulocyte count,51318,0.0413926714873087,0.00718223905256469,0.0273154829442819,0.0554698600303355,8.36307095481972e-09
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30260.Mean reticulocyte volume,51318,-0.018799756808777,0.00660080491946417,-0.0317373344509268,-0.00586217916662727,0.00440215479937547
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30270.Mean sphered cell volume,51318,-0.000477211867663205,0.00668692298654715,-0.0135835809212956,0.0126291571859692,0.943107956140078
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30280.Immature reticulocyte fraction,51318,0.00750853409586128,0.00696719456694497,-0.00614716725535086,0.0211642354470734,0.281180144905693
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,51318,0.0330643687257431,0.00718955482814221,0.0189728412625844,0.0471558961889019,4.26986443105733e-06
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30300.High light scatter reticulocyte count,51318,0.0330286797769448,0.00729052441259313,0.0187392519282623,0.0473181076256274,5.9191784123494e-06
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30500.Microalbumin in urine,37224,0.0260747077410904,0.0109831790099172,0.00454767688165264,0.0476017386005281,0.0176171475788094
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51696,-0.00762838575987847,0.00729458931055904,-0.0219257808085742,0.00666900928881725,0.295683337098034
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30520.Potassium in urine,51658,-0.0104704438344435,0.00684885453514586,-0.0238941987233294,0.00295331105444239,0.126331189312
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30530.Sodium in urine,51638,-0.00794113558627386,0.0072072908335982,-0.0220674256201263,0.00618515444757862,0.270551845516362
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30600.Albumin,49454,0.0445230565042427,0.00704956422359794,0.0307059106259907,0.0583402023824947,2.74502499657638e-10
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30610.Alkaline phosphatase,51287,0.0586389631814782,0.00694005057225345,0.0450364640598615,0.072241462303095,3.1076147594392e-17
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30620.Alanine aminotransferase,51290,0.020859119665102,0.00739763202501325,0.00635976089607608,0.035358478434128,0.00481110090422165
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30630.Apolipoprotein A,49308,-0.00673838095507017,0.00774506317510232,-0.0219187047782707,0.00844194286813038,0.3842983687247
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30640.Apolipoprotein B,51184,0.0688583870239769,0.00644565087559502,0.0562249113078107,0.0814918627401431,1.42179867477186e-26
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30650.Aspartate aminotransferase,51228,-0.00607041221260079,0.00707509953068764,-0.0199376072927486,0.00779678286754699,0.390903605506172
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30660.Direct bilirubin,48060,-0.0379337836209768,0.00743958522801392,-0.0525153706678841,-0.0233521965740695,3.44917680147545e-07
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30670.Urea,51274,-0.0126073453251277,0.00683381136462352,-0.0260016155997898,0.000786924949534428,0.0650729921130109
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30680.Calcium,49457,0.0802181313752123,0.00681600228966884,0.0668587668874614,0.0935774958629632,7.15399261922478e-32
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30690.Cholesterol,51293,0.0649814710909092,0.00650631120822904,0.0522291011227803,0.0777338410590381,1.93947254235365e-23
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30700.Creatinine,51285,-0.0339297912254285,0.00759729074999092,-0.0488204810954107,-0.0190391013554463,8.00761709610743e-06
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30710.C-reactive protein,51228,0.103523780636846,0.00736470911989997,0.0890889507618421,0.11795861051185,1.09278021755525e-44
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30720.Cystatin C,51301,0.0190304587990013,0.00752921796504102,0.00427319158752089,0.0337877260104817,0.0114931255119546
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30730.Gamma glutamyltransferase,51287,0.0674440199195993,0.00744097992164849,0.0528596992731683,0.0820283405660304,1.36129185239996e-19
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30740.Glucose,49439,0.0322968700178503,0.00701728077360313,0.0185429997015882,0.0460507403341125,4.20030617923231e-06
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),51251,0.0343075979937676,0.00714224180444252,0.0203088040570602,0.0483063919304749,1.56957226920451e-06
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30760.HDL cholesterol,49446,-0.0274839692099647,0.00793446177867662,-0.0430355142961709,-0.0119324241237585,0.000533558348407605
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30770.IGF-1,51165,-0.00306686586864006,0.00679681641752834,-0.0163886260469956,0.0102548943097155,0.651834774949922
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30780.LDL direct,51243,0.0643183388892507,0.00637544125051185,0.0518224740382474,0.0768142037402539,7.00205881429708e-24
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30790.Lipoprotein A,46814,1.22618367827075e-05,0.0073096251602213,-0.014314603477251,0.0143391271508165,0.998661574753691
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30810.Phosphate,49416,0.0545207787386761,0.00732535040430679,0.0401630919462348,0.0688784655311174,1.02552472115155e-13
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30830.SHBG,49282,-0.0605949365669838,0.00850036593066582,-0.0772556537910888,-0.0439342193428788,1.04901053906136e-12
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30840.Total bilirubin,51207,-0.0631851804738177,0.00714488447227207,-0.0771891540394709,-0.0491812069081644,9.96733806731774e-19
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30850.Testosterone,48708,-0.0227549860353395,0.01132821181515,-0.0449582811930335,-0.000551690877645523,0.0445826429939249
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30860.Total protein,49438,0.143825988688851,0.00677236843396275,0.130552146558284,0.157099830819418,5.20540602037982e-99
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30870.Triglycerides,51279,0.117214449573251,0.00740937547340354,0.10269207364538,0.131736825501122,4.62212703270741e-56
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30880.Urate,51258,0.0368731139065024,0.0080006178111801,0.0211919029965894,0.0525543248164154,4.07299290699462e-06
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30890.Vitamin D,50159,-0.0344610946933826,0.00756211420834315,-0.0492828385417352,-0.01963935084503,5.21644248813984e-06
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X3137.Number of measurements made,49825,-0.0107824847715612,0.0166400309211226,-0.0433969453769615,0.021831975833839,0.517002083647502
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X3143.Ankle spacing width,42318,-0.01284106785024,0.0116436129530108,-0.0356625492381412,0.00998041353766125,0.270115916122781
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",42317,-0.0196010241201055,0.00907565757175039,-0.0373893129607362,-0.00181273527947471,0.0308111683784529
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X3146.Speed of sound through heel,42318,-0.0296327826014441,0.00868675673186045,-0.0466588257958906,-0.0126067394069976,0.000648584218232813
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",42318,-0.0270324348085931,0.00879559422744837,-0.0442717994943919,-0.00979307012279431,0.00212064124236789
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X3148.Heel bone mineral density (BMD),42307,-0.0257288501881148,0.00880765922607569,-0.0429918622712232,-0.0084658381050065,0.00349291113015032
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X3526.Mother's age at death,48428,-0.00268511014824374,0.00686253463859472,-0.0161356780398894,0.0107654577434019,0.695601335649571
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X3581.Age at menopause (last menstrual period),38539,0.0124413752334536,0.00950031286518492,-0.00617923798230889,0.031061988449216,0.19037173410218
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32830,-0.00135831817274828,0.014888581564978,-0.0305399380401051,0.0278233016946085,0.927313108767394
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4100.Ankle spacing width (left),36796,-0.0255327977100157,0.0148803555926746,-0.0546982946716578,0.00363269925162645,0.0862260668474825
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),36793,-0.00682865291702178,0.0115272147618781,-0.0294219938503028,0.0157646880162592,0.553604406000648
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4103.Speed of sound through heel (left),36796,-0.00755096777018133,0.0110150912733346,-0.0291405466659172,0.0140386111255546,0.493042336730345
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",36796,-0.00854164671557685,0.0111637194468857,-0.0304225368314728,0.0133392434003191,0.444220552849967
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4105.Heel bone mineral density (BMD) (left),36791,-0.00828943467056941,0.0111650080767477,-0.0301728505009949,0.013593981159856,0.457839077206346
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",36796,-0.00853148809722912,0.0111636951238862,-0.0304123305400461,0.0133493543455878,0.444761523191974
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4119.Ankle spacing width (right),36794,-0.010415217023307,0.0146531028534878,-0.039135298616143,0.0183048645695291,0.477238810340316
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),36793,-0.0161972061797736,0.0114999530397457,-0.0387371141376752,0.00634270177812798,0.159036270241583
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4122.Speed of sound through heel (right),36794,-0.0113873380044502,0.0109714402798445,-0.0328913609529455,0.0101166849440451,0.29934623266113
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",36794,-0.013237487045065,0.0111267670043438,-0.0350459503735789,0.00857097628344886,0.234202467214796
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4124.Heel bone mineral density (BMD) (right),36789,-0.0107412414786073,0.0111162942860322,-0.0325291782792305,0.0110466953220158,0.333944368918265
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",36794,-0.0132347300302911,0.0111267691176686,-0.0350431975009215,0.00857373744033922,0.234299988182735
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4194.Pulse rate,37148,0.0450180125938856,0.010494523079346,0.0244487473583675,0.0655872778294036,1.81057719453472e-05
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4195.Pulse wave reflection index,37148,-0.0137718512284469,0.0113629779794177,-0.0360432880681056,0.0084995856112118,0.225551012079823
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4196.Pulse wave peak to peak time,37143,-0.0237138669799982,0.0103823318628705,-0.0440632374312243,-0.00336449652877201,0.0223942632255418
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4198.Position of the pulse wave peak,37148,0.0213295533486807,0.0111097707632105,-0.000445597347211977,0.0431047040445733,0.0549073446212637
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4199.Position of pulse wave notch,37148,0.0276680083514895,0.0106145110291618,0.00686356673433235,0.0484724499686466,0.0091611064422212
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4200.Position of the shoulder on the pulse waveform,37148,0.0270160983037452,0.0109395919698032,0.00557449804293093,0.0484576985645595,0.013548359437587
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4269.Number of triplets attempted (left),36956,-0.0470899053736686,0.0651922215394445,-0.17486665959098,0.0806868488436426,0.470117108846713
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4270.Volume level set by participant (left),36865,0.00617548686030882,0.0222495466486127,-0.037433624570972,0.0497845982915896,0.781360981445901
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4276.Number of triplets attempted (right),36952,-0.0389778091766592,0.0636292385961336,-0.163691116825081,0.0857354984717628,0.540174043600795
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4277.Volume level set by participant (right),36857,-0.00792707493207313,0.0221314204709457,-0.0513046590551268,0.0354505091909805,0.720217037850281
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X4288.Time to answer,37152,0.0189409925152373,0.0124202054018931,-0.00540261007247312,0.0432845951029477,0.12729523547685
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X4290.Duration screen displayed,37152,0.0240987845166783,0.0117207353296425,0.00112614327057892,0.0470714257627776,0.0398072252260259
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X46.Hand grip strength (left),52312,-0.0294507103662926,0.00940444418639049,-0.047883420971618,-0.0110179997609673,0.00174088907137176
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X47.Hand grip strength (right),52337,-0.0206249264553822,0.00934112017782708,-0.0389335220039233,-0.00231633090684115,0.0272560344185767
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X48.Waist circumference,52400,0.101256545392751,0.0141985413284788,0.0734274043889325,0.12908568639657,1.02211426362174e-12
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X4803.Tinnitus,37052,0.0222929271457156,0.0250997008101152,-0.0269024864421102,0.0714883407335414,0.374473811709767
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X4825.Noisy workplace,37132,0.0601420100204406,0.0288576971568929,0.00358092359293061,0.116703096447951,0.037183977138573
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X4836.Loud music exposure frequency,37086,0.0421848808052947,0.0482711919748225,-0.0524266554653575,0.136796417075947,0.382191571239402
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X49.Hip circumference,52395,-0.0285561160872307,0.011592000237001,-0.0512764365517528,-0.00583579562270866,0.0137685638826778
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X50.Standing height,52375,-0.0299692486540884,0.00922017941118045,-0.0480408003000021,-0.0118976970081747,0.00115408154588562
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X5057.Number of older siblings,35910,0.0371577739720887,0.0242798054540613,-0.0104306447178715,0.0847461926620489,0.125965264208398
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X51.Seated height,52282,-0.0325957539862305,0.00860816440889037,-0.0494677562276557,-0.0157237517448054,0.000153103719737555
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5181.Ever had eye surgery,34536,-0.00182268135853725,0.0499508127001501,-0.0997262742508314,0.0960809115337569,0.970893396018585
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5186.Duration visual-acuity screen displayed (right),34521,0.016385264242158,0.0127380217928312,-0.00858125847179118,0.0413517869561072,0.198384787055621
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5188.Duration visual-acuity screen displayed (left),34521,0.0356513104609956,0.0130882438584781,0.0099983524983785,0.0613042684236126,0.0064722807038134
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5190.Duration at which refractometer first shown (right),34448,0.0292437312920325,0.0134520404222568,0.00287773206440916,0.0556097305196558,0.0297552415576792
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5193.Duration at which refractometer first shown (left),34447,0.0351665471940295,0.013568344814763,0.00857259135709407,0.061760503030965,0.00957372989340164
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5199.logMAR, initial (right)",34504,0.0598559550726848,0.0285409753435732,0.00391564339928135,0.115796266746088,0.0360236073151637
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5200.Final number of letters displayed (right),34504,-0.177610777104189,0.175643311229732,-0.521871667114464,0.166650112906087,0.311966096904129
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5201.logMAR, final (right)",34446,0.0146342693157282,0.0140732856954939,-0.0129493706474399,0.0422179092788963,0.298452074986956
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5202.Number of rounds to result (right),34504,0.0650736385130629,0.0264609207238497,0.0132102338943174,0.116937043131808,0.0139550495783745
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5206.logMAR, initial (left)",34501,0.0567013602435851,0.0287314566994174,0.000387705112726962,0.113015015374443,0.0484911031837926
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5207.Final number of letters displayed (left),34501,-0.13011487553778,0.158691906502587,-0.441151012282851,0.180921261207291,0.412297804962884
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5208.logMAR, final (left)",34441,0.00964077563892879,0.0140284107044678,-0.017854909341828,0.0371364606196856,0.491966785588464
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5209.Number of rounds to result (left),34499,0.0673004194908271,0.0264271089651637,0.0155032859191064,0.119097553062548,0.0109045234411077
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",34243,0.0142481290500629,0.0131021553397818,-0.0114320954159095,0.0399283535160353,0.276883480146554
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",34243,0.0215393256628294,0.0132359195381167,-0.00440307663187939,0.0474817279575381,0.103727555569666
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5256.Corneal hysteresis (right),34243,0.0117211522115539,0.013225132513046,-0.0142001075140163,0.0376424119371241,0.375509616324341
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5257.Corneal resistance factor (right),34243,0.0219914455155319,0.0133410081484917,-0.00415693045551193,0.0481398214865757,0.0993308705112081
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",34235,0.025126190368646,0.013079722171569,-0.000510065087629321,0.0507624458249213,0.0547876185658011
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",34235,0.0309007307665249,0.0132079644834771,0.0050131203789098,0.05678834115414,0.0193456750162964
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5264.Corneal hysteresis (left),34235,0.0031617913777184,0.0134009536527495,-0.0231040777816706,0.0294276605371074,0.813490529281805
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5265.Corneal resistance factor (left),34235,0.0211968833170557,0.0134454499998914,-0.00515619868273136,0.0475499653168428,0.114971116969021
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,34645,-0.107149881719076,0.14756849969027,-0.396384141112006,0.182084377673854,0.467807012533724
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",52338,-0.022054340316231,0.0348141901216895,-0.0902901529547425,0.0461814723222805,0.526421862593896
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",52338,-0.0814500060716365,0.0368094100434335,-0.153596449756766,-0.00930356238650688,0.0269246382843932
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",52338,-0.106593004782266,0.0979930987916656,-0.298659478413931,0.0854734688493987,0.276712257175331
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",52338,-0.015955470961912,0.0149687581188351,-0.0452942368748289,0.0133832949510049,0.286471762924436
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",52338,0.0213360064357639,0.014088965574497,-0.00627836609025029,0.0489503789617781,0.129943886775087
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",38345,0.00835293941336312,0.0202909208825003,-0.0314172655163374,0.0481231443430636,0.680599049929375
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",38345,0.046891670786981,0.0432949714852492,-0.0379664733241074,0.131749814898069,0.278803983365608
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",38345,-0.0534470428097349,0.0534705074198883,-0.158249237352716,0.0513551517332461,0.317549353490278
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",38345,0.0449784279338314,0.0288010996810933,-0.0114717274411115,0.101428583308774,0.118395299658495
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,52412,-0.0312403059157076,0.0292577937269949,-0.0885855816206175,0.0261049697892024,0.285639824316598
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,52412,-0.0312403059157076,0.0292577937269949,-0.0885855816206175,0.0261049697892024,0.285639824316598
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),52412,0.0256268954741723,0.0234050362655761,-0.0202469756063569,0.0715007665547014,0.273558305029952
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',52412,-0.019412869893716,0.0405540868731505,-0.0988988801650909,0.0600731403776588,0.632163091216492
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),52412,0.0458787909941467,0.0977491356377518,-0.145709514855847,0.23746709684414,0.638822176599993
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),52412,0.0138143504861857,0.0661910129152281,-0.115920034827661,0.143548735800033,0.83468089662286
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,52412,0.237679603153206,0.107992286240774,0.02601472212129,0.449344484185122,0.0277533171474931
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,52338,0.0366975466750165,0.0216542046504746,-0.00574469443991377,0.0791397877899467,0.0901443432821425
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,52338,0.0255135148619709,0.0365283761334403,-0.0460821023595721,0.097109132083514,0.484898203888252
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,52338,0.0108398617909097,0.0216267534852743,-0.0315485750402279,0.0532282986220474,0.616217800168774
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,52338,0.0483030079564468,0.0306074432762403,-0.0116875808649842,0.108293596777878,0.114545785906894
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,52338,0.0376787902168975,0.0370695355755359,-0.0349774995111529,0.110335079944948,0.30943269499343
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,52338,0.0207982378780205,0.0144779440461636,-0.00757853245246028,0.0491750082085012,0.150860450245289
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,38906,-0.122368220512182,0.0328438583973613,-0.18674218297101,-0.0579942580533534,0.000195834295162861
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,38906,-0.061415467572529,0.0281109338911148,-0.116512897999114,-0.00631803714594388,0.0289307293148324
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,38906,0.0204472885369332,0.0406397640100655,-0.0592066489227951,0.100101225996661,0.614880755436631
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,38906,0.0973452194007455,0.0316802130470221,0.0352520018285821,0.159438436972909,0.00212686995486198
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,52331,-0.0214631474472997,0.049481332962228,-0.118446560053267,0.0755202651586672,0.664464948735915
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,52331,0.0689607568563628,0.0759742186589869,-0.0799487117152516,0.217870225427977,0.364053441777195
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,52331,-0.030645383867904,0.117446591221681,-0.260840702662399,0.199549934926591,0.794148517345826
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,52331,-0.052186492545997,0.12597246238432,-0.299092518819265,0.194719533727271,0.678680916627534
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,52331,-0.0319967277341312,0.0409653666083723,-0.112288846286541,0.0482953908182785,0.43477062553645
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,52331,0.122877029747211,0.056780568170368,0.01158711613329,0.234166943361133,0.0304693030299286
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,52331,0.0218805459016827,0.0299450111550816,-0.0368116759622772,0.0805727677656426,0.46497539953491
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",36060,0.0611548342698688,0.0404735723384331,-0.01817336751346,0.140483036053198,0.130839087973233
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",36060,0.0423701973722365,0.0422822574216698,-0.0405030271742364,0.125243421918709,0.316340351926412
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",36060,-0.070819758437812,0.0593341060108176,-0.187114606219014,0.0454750893433905,0.23268514773838
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",36060,0.052268117141738,0.0247508491649072,0.00375645277851977,0.100779781504956,0.034742153290894
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",40631,-0.0295025052680881,0.0191767874486987,-0.0670890086675376,0.00808399813136134,0.123966586869725
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",40631,0.0195235738493766,0.0226462907126277,-0.0248631559473737,0.0639103036461269,0.388645546314567
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",40631,0.0576252703732992,0.018758031722225,0.0208595281977382,0.0943910125488602,0.00213106591407686
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",40631,0.0837752704435497,0.043286927097654,-0.00106710666785212,0.168617647554951,0.0529722182385285
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",40631,-0.000368369210891527,0.0240838016414924,-0.0475726204282166,0.0468358820064335,0.987796850955796
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",40631,-0.0470807508401497,0.034374762351267,-0.114455285048633,0.0202937833683335,0.170828910259927
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,52338,0.0215857989866552,0.0403976712778538,-0.0575936367179382,0.100765234691249,0.593116466662909
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,52338,0.0472502326095062,0.030451803956606,-0.0124353031454414,0.106935768364454,0.120762095142226
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,52338,0.0139812548813022,0.0768270719772861,-0.136599806194178,0.164562315956783,0.855597315256627
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,52338,0.00153419676115625,0.0284888896681078,-0.054304026988335,0.0573724205106475,0.957053178738634
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,52338,0.074754320149818,0.0335574692722156,0.00898168037627535,0.140526959923361,0.0259133918647222
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),52338,0.0163845840551886,0.0401919808302976,-0.0623916983721946,0.0951608664825719,0.683528518999695
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,52338,-0.0404710270654761,0.0135351187154832,-0.0669998597478231,-0.013942194383129,0.00279201736243693
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,34939,-0.0335378907537874,0.0344458301589889,-0.101051717865406,0.0339759363578309,0.33027554386614
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,34939,0.00779148665411909,0.0423339214431651,-0.0751829993744846,0.0907659726827227,0.853982051640872
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,34939,-0.0270627291106786,0.029545986504504,-0.0849728626595063,0.0308474044381492,0.359730089163439
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,34939,0.0265162781449952,0.0277678586040911,-0.0279087247190233,0.0809412810090137,0.339654781613599
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52437,0.0235502828180416,0.018079807236586,-0.011886139365667,0.0589867050017502,0.192733220612106
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52437,0.0507419230144919,0.0500793342501184,-0.0474135721157401,0.148897418144724,0.310960487739071
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52437,0.0278235659780175,0.0150455244343328,-0.00166566191327476,0.0573127938693098,0.0644283673222511
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52437,-0.00671469736755826,0.0144857918899007,-0.0351068494717636,0.0216774547366471,0.64298399630092
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52437,0.0208403615297479,0.0246012517866184,-0.0273780919720241,0.0690588150315199,0.396933582555246
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52437,-0.00590627956208887,0.0184752845155964,-0.0421178372126578,0.0303052780884801,0.749209667292682
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52437,0.00427590507003817,0.0151371039300479,-0.0253928186328557,0.0339446287729321,0.777579213369579
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52437,0.153078214370588,0.0463870274586425,0.0621596405516484,0.243996788189527,0.000968226782637152
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,45744,-0.0165571698456072,0.0157173712281853,-0.0473632174528504,0.014248877761636,0.292158772346873
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,45744,-0.0103597920098921,0.0163190783566182,-0.0423451855888638,0.0216256015690796,0.525550009345365
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,45744,-0.000146500704820596,0.0172927612263287,-0.0340403127084248,0.0337473112987837,0.993240669606987
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,45744,-0.031554171984218,0.0236395408504665,-0.0778876720511323,0.0147793280826963,0.181958612234011
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,45744,-0.0103611003535619,0.0157817749160323,-0.0412933791889852,0.0205711784818614,0.511496714718757
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,52201,-0.0118321134399245,0.0158760931206249,-0.0429492559563493,0.0192850290765002,0.456110891119093
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,52201,0.00274249713441595,0.0128860399418688,-0.0225141411516468,0.0279991354204787,0.831463794148257
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,52201,-0.0132965054534626,0.0133392800377434,-0.0394414943274397,0.0128484834205145,0.318875316790059
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,52201,-0.00245486002991397,0.0288784763111798,-0.0590566735998263,0.0541469535399984,0.932256912345532
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),52220,-0.0311613166609786,0.0143235478554468,-0.0592354704576544,-0.00308716286430282,0.0296005138811972
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,52220,-0.0125665598746181,0.0283349182809456,-0.0681029997052716,0.0429698799560354,0.657407683487528
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),52338,0.0103184914202611,0.0130717473507078,-0.0153021333871262,0.0359391162276484,0.429901805425707
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,52338,0.00114415300030939,0.0149706044142548,-0.02819823165163,0.0304865376522487,0.939080336210498
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,52338,-0.0330176339743546,0.0227006393683183,-0.0775108871362584,0.0114756191875493,0.145826737665337
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,52338,-0.0018764391802396,0.0312647524652411,-0.0631553540121121,0.0594024756516329,0.952142039279519
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,52338,0.0144888837169786,0.0396734381100545,-0.0632710549787283,0.0922488224126855,0.71496274407528
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,52338,0.012738943496553,0.0374916464773508,-0.0607446835990545,0.0862225705921605,0.734024653862829
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",42318,-0.0270311558807668,0.00879555142403566,-0.0442704366718767,-0.00979187508965687,0.00212156787530468
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X864.Number of days or week walked 10+ minutes,51841,-0.0167442346601271,0.0128223296244792,-0.0418760007241063,0.0083875314038521,0.191611653944301
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X874.Duration of walks,48720,-0.00863840412509695,0.00713188849761921,-0.0226169055804306,0.00534009733023671,0.225819411601543
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50893,-0.00462482143244874,0.0123426480157319,-0.0288164115432832,0.0195667686783857,0.707885373628447
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X894.Duration of moderate activity,46003,-0.0022886283274394,0.0152336533922801,-0.0321465889763085,0.0275693323214297,0.880580994710125
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X90087.No-wear time bias adjusted average acceleration,33499,0.00357572405798892,0.0167098375634087,-0.0291755575662921,0.0363270056822699,0.830565646753997
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50792,-0.00641589010892973,0.0127773481657272,-0.031459492513755,0.0186277122958956,0.615581183908134
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X914.Duration of vigorous activity,40449,0.0066785448533211,0.0088185484643542,-0.0106058101368131,0.0239628998434553,0.448868474738748
